Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix structural constituent	VWF COL19A1 LAMA2 LAMA3 LAMA4 LAMC1 POSTN SLIT2 FBN1 PXDN LTBP2 MUC2	1.63e-08	188	148	12	GO:0005201
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	ZNF695 ZNF266 ZNF569 ZNF273 ZSCAN26 ZNF300 LHX8 PRDM5 ZNF354C ZNF551 ZNF260 ZNF248 ZNF461 ZNF12 GTF2IRD2B ZNF26 ZNF33A ZNF33B ZNF846 GTF2IRD2 ZBTB40 ZNF624 ZNF616 ZNF90 ZNF107 ZNF679 ZNF418 PRDM15 ZNF286A ZNF572	1.33e-07	1412	148	30	GO:0000981
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	ZNF695 ZNF266 ZNF569 ZNF273 ZSCAN26 NSD1 ZNF300 LHX8 PRDM5 ZNF354C ZNF551 ZNF260 ZNF248 ZNF461 ZNF12 ZNF26 ZNF33A ZNF33B ZNF846 ZNF624 ZNF616 ZNF90 ZNF107 ZNF679 ZNF418 PRDM15 TET3 ZNF286A ZNF572	8.89e-07	1459	148	29	GO:0000977
GeneOntologyMolecularFunction	heparin binding	POSTN SLIT2 FBN1 FURIN LPL SLIT1 ADAMTS15 LTBP2 TWSG1 RSPO1	1.73e-06	192	148	10	GO:0008201
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	ZNF695 ZNF569 ZNF273 ZSCAN26 NSD1 ZNF300 PRDM5 ZNF354C ZNF551 ZNF260 ZNF461 ZNF12 ZNF26 ZNF33A ZNF33B ZNF624 ZNF616 ZNF90 ZNF107 ZNF679 ZNF418 PRDM15 TET3 ZNF286A ZNF572	4.71e-06	1244	148	25	GO:0000978
GeneOntologyMolecularFunction	glycosaminoglycan binding	STAB2 POSTN SLIT2 FBN1 FURIN LPL SLIT1 ADAMTS15 LTBP2 TWSG1 RSPO1	5.23e-06	268	148	11	GO:0005539
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	ZNF695 ZNF569 ZNF273 ZSCAN26 NSD1 ZNF300 PRDM5 ZNF354C ZNF551 ZNF260 ZNF461 ZNF12 ZNF26 ZNF33A ZNF33B ZNF624 ZNF616 ZNF90 ZNF107 ZNF679 ZNF418 PRDM15 TET3 ZNF286A ZNF572	6.85e-06	1271	148	25	GO:0000987
GeneOntologyMolecularFunction	calcium ion binding	VLDLR STAB2 VWCE RPH3A EGFEM1P LRP8 SLIT2 EYS FBN1 EGF MEGF6 LPL SLIT1 PCDH15 ADGRE4P SCUBE3 LTBP2	4.14e-05	749	148	17	GO:0005509
GeneOntologyMolecularFunction	reelin receptor activity	VLDLR LRP8	5.46e-05	2	148	2	GO:0038025
GeneOntologyMolecularFunction	lipoprotein particle binding	VLDLR STAB2 LRP8 LPL	1.27e-04	35	148	4	GO:0071813
GeneOntologyMolecularFunction	protein-lipid complex binding	VLDLR STAB2 LRP8 LPL	1.27e-04	35	148	4	GO:0071814
GeneOntologyMolecularFunction	sulfur compound binding	POSTN SLIT2 FBN1 FURIN LPL SLIT1 ADAMTS15 LTBP2 TWSG1 RSPO1	1.52e-04	323	148	10	GO:1901681
GeneOntologyMolecularFunction	growth factor binding	PDGFA NLRP2 PXDN FURIN KDR LTBP2 TWSG1	1.65e-04	156	148	7	GO:0019838
GeneOntologyMolecularFunction	low-density lipoprotein particle receptor activity	VLDLR STAB2 LRP8	2.08e-04	16	148	3	GO:0005041
GeneOntologyMolecularFunction	metalloendopeptidase activity	TMPRSS6 ADAM7 ADAM28 ADAM22 MEP1B ADAMTS15	2.73e-04	120	148	6	GO:0004222
GeneOntologyMolecularFunction	histone H3 methyltransferase activity	NSD2 NSD1 EZH1 SETDB2	3.12e-04	44	148	4	GO:0140938
GeneOntologyMolecularFunction	very-low-density lipoprotein particle receptor activity	VLDLR LRP8	3.24e-04	4	148	2	GO:0030229
GeneOntologyMolecularFunction	histone H3K36 dimethyltransferase activity	NSD2 NSD1	3.24e-04	4	148	2	GO:0140954
GeneOntologyMolecularFunction	apolipoprotein binding	VLDLR LRP8 LPL	4.15e-04	20	148	3	GO:0034185
GeneOntologyMolecularFunction	lipoprotein particle receptor activity	VLDLR STAB2 LRP8	4.81e-04	21	148	3	GO:0030228
GeneOntologyMolecularFunction	signaling receptor regulator activity	PDGFA PDYN WNT4 DEFB130B IFNA5 SLIT2 FBN1 PXDN EGF INSL6 DEFB130A C5 CCL18	6.85e-04	616	148	13	GO:0030545
GeneOntologyMolecularFunction	receptor ligand activity	PDGFA PDYN WNT4 DEFB130B IFNA5 SLIT2 FBN1 EGF INSL6 DEFB130A C5 CCL18	7.90e-04	547	148	12	GO:0048018
GeneOntologyMolecularFunction	signaling receptor activator activity	PDGFA PDYN WNT4 DEFB130B IFNA5 SLIT2 FBN1 EGF INSL6 DEFB130A C5 CCL18	8.82e-04	554	148	12	GO:0030546
GeneOntologyMolecularFunction	heparan sulfate proteoglycan binding	SLIT2 LPL SLIT1	1.27e-03	29	148	3	GO:0043395
GeneOntologyMolecularFunction	laminin-1 binding	SLIT2 PXDN	1.48e-03	8	148	2	GO:0043237
GeneOntologyMolecularFunction	protein-lysine N-methyltransferase activity	NSD2 NSD1 EZH1 SETDB2	1.63e-03	68	148	4	GO:0016279
GeneOntologyMolecularFunction	lysine N-methyltransferase activity	NSD2 NSD1 EZH1 SETDB2	1.72e-03	69	148	4	GO:0016278
GeneOntologyMolecularFunction	histone methyltransferase activity	NSD2 NSD1 EZH1 SETDB2	1.92e-03	71	148	4	GO:0042054
GeneOntologyMolecularFunction	extracellular matrix binding	SLIT2 PXDN ADAMTS15 LTBP2	2.12e-03	73	148	4	GO:0050840
GeneOntologyMolecularFunction	protease binding	VWF SPATA2 FAS NLRP2 FURIN TNFRSF1A	2.33e-03	181	148	6	GO:0002020
GeneOntologyMolecularFunction	histone H4K20 methyltransferase activity	NSD2 NSD1	2.36e-03	10	148	2	GO:0042799
GeneOntologyMolecularFunction	zinc ion binding	TCEA2 ZSWIM5 NSD1 RPH3A RBM20 MEP1B IFIH1 SETDB2 SMPDL3A ADAMTS15 NEIL3 ZMYM1 ZNF90 TET3 ZMYM3	2.58e-03	891	148	15	GO:0008270
GeneOntologyMolecularFunction	ATP-dependent diacylglycerol kinase activity	DGKD DGKH	2.87e-03	11	148	2	GO:0004143
GeneOntologyMolecularFunction	transition metal ion binding	TCEA2 ZSWIM5 NSD1 RPH3A RBM20 MEP1B IFIH1 SETDB2 SMPDL3A CIAPIN1 TPH2 ADAMTS15 NEIL3 ZMYM1 ZNF90 MUC2 TET3 ZMYM3	3.09e-03	1189	148	18	GO:0046914
GeneOntologyMolecularFunction	chemokine receptor binding	DEFB130B DEFB130A C5 CCL18	3.10e-03	81	148	4	GO:0042379
GeneOntologyMolecularFunction	Roundabout binding	SLIT2 SLIT1	3.43e-03	12	148	2	GO:0048495
GeneOntologyMolecularFunction	interleukin-1 binding	NLRP2 PXDN	3.43e-03	12	148	2	GO:0019966
GeneOntologyMolecularFunction	tumor necrosis factor receptor activity	FAS TNFRSF1A	3.43e-03	12	148	2	GO:0005031
GeneOntologyMolecularFunction	extracellular matrix constituent conferring elasticity	LAMC1 FBN1	3.43e-03	12	148	2	GO:0030023
GeneOntologyMolecularFunction	cargo receptor activity	VLDLR STAB2 EGFEM1P LRP8	3.69e-03	85	148	4	GO:0038024
GeneOntologyMolecularFunction	metallopeptidase activity	TMPRSS6 ADAM7 ADAM28 ADAM22 MEP1B ADAMTS15	3.81e-03	200	148	6	GO:0008237
GeneOntologyMolecularFunction	CCR6 chemokine receptor binding	DEFB130B DEFB130A	4.03e-03	13	148	2	GO:0031731
GeneOntologyMolecularFunction	histone H3K36 methyltransferase activity	NSD2 NSD1	4.03e-03	13	148	2	GO:0046975
GeneOntologyMolecularFunction	structural molecule activity conferring elasticity	LAMC1 FBN1	4.68e-03	14	148	2	GO:0097493
GeneOntologyMolecularFunction	inositol 1,4,5 trisphosphate binding	TRPC1 RPH3A	4.68e-03	14	148	2	GO:0070679
GeneOntologyMolecularFunction	methyltransferase activity	NSD2 NSD1 EZH1 PRDM5 SETDB2 PRDM15	5.17e-03	213	148	6	GO:0008168
GeneOntologyCellularComponent	external encapsulating structure	VWF COL19A1 LAMA2 LAMA3 LAMA4 LAMC1 WNT4 PKHD1L1 POSTN SLIT2 EYS FBN1 PXDN MEGF6 CLU OTOGL ADAMTS15 LTBP2 MUC2 USH2A	9.42e-08	658	155	20	GO:0030312
GeneOntologyCellularComponent	extracellular matrix	VWF COL19A1 LAMA2 LAMA3 LAMA4 LAMC1 WNT4 POSTN SLIT2 EYS FBN1 PXDN MEGF6 CLU OTOGL ADAMTS15 LTBP2 MUC2 USH2A	4.23e-07	656	155	19	GO:0031012
GeneOntologyCellularComponent	collagen-containing extracellular matrix	VWF COL19A1 LAMA2 LAMA3 LAMA4 LAMC1 POSTN SLIT2 EYS FBN1 PXDN MEGF6 CLU ADAMTS15 LTBP2 MUC2 USH2A	4.42e-07	530	155	17	GO:0062023
GeneOntologyCellularComponent	cell surface	CACNA1D VLDLR RC3H2 STAB2 VWF PDGFA WNT4 FAS VWDE ADAM28 LRP8 SLIT2 PXDN CLU FURIN MICB LPL ADGRE4P ADAMTS15 SCUBE3 SCNN1G KDR PLAUR ROS1 TNFRSF1A	6.55e-07	1111	155	25	GO:0009986
GeneOntologyCellularComponent	membrane attack complex	C5 C6 C7	1.37e-05	7	155	3	GO:0005579
GeneOntologyCellularComponent	basement membrane	LAMA2 LAMA3 LAMA4 LAMC1 FBN1 PXDN USH2A	3.53e-05	122	155	7	GO:0005604
GeneOntologyCellularComponent	protein complex involved in cell-matrix adhesion	LAMA2 LAMC1 PLAUR	2.52e-04	17	155	3	GO:0098637
GeneOntologyCellularComponent	endoplasmic reticulum lumen	COL19A1 PDGFA LAMC1 WNT4 FBN1 CLU AFP FURIN PLAUR	8.53e-04	332	155	9	GO:0005788
GeneOntologyCellularComponent	pore complex	C5 C6 C7	9.17e-04	26	155	3	GO:0046930
GeneOntologyCellularComponent	protein complex involved in cell adhesion	LAMA2 LAMC1 GLIPR1L1 PLAUR	9.64e-04	59	155	4	GO:0098636
GeneOntologyCellularComponent	neuromuscular junction	LAMA2 LAMA4 LAMC1 RPH3A POSTN	1.49e-03	112	155	5	GO:0031594
GeneOntologyCellularComponent	platelet alpha granule lumen	VWF PDGFA EGF CLU	1.55e-03	67	155	4	GO:0031093
GeneOntologyCellularComponent	synaptic cleft	LAMA2 LAMA4 LAMC1	1.85e-03	33	155	3	GO:0043083
HumanPheno	Recurrent meningococcal disease	C5 C6 C7	1.54e-05	6	48	3	HP:0005381
HumanPheno	Decreased circulating terminal complement component concentration	C5 C6 C7	1.54e-05	6	48	3	HP:0033057
HumanPheno	Recurrent Neisserial infections	C5 C6 C7	2.68e-05	7	48	3	HP:0005430
Domain	EGF-like_dom	ATRN VLDLR STAB2 LAMA2 LAMA3 LAMA4 LAMC1 VWCE VWDE ADAM28 ADAM22 LRP8 MEP1B SLIT2 EYS FBN1 EGF MEGF6 ATRNL1 SLIT1 ADGRE4P SCUBE3 LTBP2 C6 C7	1.77e-20	249	150	25	IPR000742
Domain	EGF_1	ATRN VLDLR STAB2 LAMA2 LAMA3 LAMA4 LAMC1 VWCE VWDE ADAM28 ADAM22 LRP8 MEP1B SLIT2 EYS FBN1 EGF MEGF6 ATRNL1 SLIT1 SCUBE3 LTBP2 C6 C7 USH2A	3.18e-20	255	150	25	PS00022
Domain	EGF-like_CS	ATRN VLDLR STAB2 LAMA2 LAMA3 LAMA4 LAMC1 VWCE VWDE ADAM28 ADAM22 LRP8 MEP1B SLIT2 EYS FBN1 EGF MEGF6 ATRNL1 SLIT1 SCUBE3 LTBP2 C6 C7	8.65e-19	261	150	24	IPR013032
Domain	EGF	ATRN VLDLR STAB2 LAMA2 LAMA3 LAMA4 LAMC1 VWCE VWDE ADAM28 ADAM22 LRP8 MEP1B SLIT2 EYS FBN1 EGF MEGF6 ATRNL1 SLIT1 ADGRE4P SCUBE3 LTBP2	1.20e-18	235	150	23	SM00181
Domain	EGF_2	ATRN VLDLR STAB2 LAMA2 LAMA3 LAMC1 VWCE VWDE ADAM28 ADAM22 LRP8 MEP1B SLIT2 EYS FBN1 EGF MEGF6 ATRNL1 SLIT1 SCUBE3 LTBP2 C6 C7	1.77e-17	265	150	23	PS01186
Domain	EGF_3	ATRN VLDLR STAB2 VWCE VWDE ADAM28 ADAM22 LRP8 MEP1B SLIT2 EYS FBN1 EGF MEGF6 ATRNL1 SLIT1 ADGRE4P SCUBE3 LTBP2 C6 C7	2.72e-16	235	150	21	PS50026
Domain	Growth_fac_rcpt_	ATRN VLDLR STAB2 EPHA6 LAMA3 LAMC1 VWCE LRP8 EYS FBN1 EGF MEGF6 FURIN SLIT1 SCUBE3 LTBP2 RSPO1	8.06e-15	156	150	17	IPR009030
Domain	zf-C2H2	ZNF695 ZNF266 ZNF569 ZNF273 ZSCAN26 ZNF300 PRDM5 ZNF354C ZNF551 ZNF260 ZNF248 ZNF461 ZNF12 ZNF26 ZNF33A ZNF33B ZNF846 ZBTB40 ZNF624 ZNF616 ZNF90 ZNF107 ZNF679 ZNF418 ZNF542P PRDM15 ZNF286A ZNF687 ZNF572	2.12e-13	693	150	29	PF00096
Domain	ZnF_C2H2	ZNF695 ZNF266 ZNF569 ZNF273 ZSCAN26 ZNF300 PRDM5 ZNF354C ZNF551 ZNF260 ZNF248 ZNF461 ZNF12 GTF2IRD2B ZNF26 ZNF33A ZNF33B ZNF846 GTF2IRD2 ZBTB40 ZNF624 ZNF616 ZNF90 ZNF107 ZNF679 ZNF418 ZNF542P PRDM15 ZNF286A ZNF687 ZNF572	2.77e-13	808	150	31	SM00355
Domain	Znf_C2H2-like	ZNF695 ZNF266 ZNF569 ZNF273 ZSCAN26 ZNF300 PRDM5 ZNF354C ZNF551 ZNF260 ZNF248 ZNF461 ZNF12 GTF2IRD2B ZNF26 ZNF33A ZNF33B ZNF846 GTF2IRD2 ZBTB40 ZNF624 ZNF616 ZNF90 ZNF107 ZNF679 ZNF418 PRDM15 ZNF286A ZNF687 ZNF572	1.13e-12	796	150	30	IPR015880
Domain	Znf_C2H2/integrase_DNA-bd	ZNF695 ZNF266 ZNF569 ZNF273 ZSCAN26 ZNF300 PRDM5 ZNF354C ZNF551 ZNF260 ZNF248 ZNF461 ZNF12 ZNF26 ZNF33A ZNF33B ZNF846 ZBTB40 ZNF624 ZNF616 ZNF90 ZNF107 ZNF679 ZNF418 PRDM15 ZNF286A ZNF687 ZNF572	1.41e-12	694	150	28	IPR013087
Domain	ZINC_FINGER_C2H2_2	ZNF695 ZNF266 ZNF569 ZNF273 ZSCAN26 ZNF300 PRDM5 ZNF354C ZNF551 ZNF260 ZNF248 ZNF461 ZNF12 ZNF26 ZNF33A ZNF33B ZNF846 ZBTB40 ZNF624 ZNF616 ZNF90 ZNF107 ZNF679 ZNF418 ZNF542P PRDM15 ZNF286A ZNF687 ZNF572	3.39e-12	775	150	29	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF695 ZNF266 ZNF569 ZNF273 ZSCAN26 ZNF300 PRDM5 ZNF354C ZNF551 ZNF260 ZNF248 ZNF461 ZNF12 ZNF26 ZNF33A ZNF33B ZNF846 ZBTB40 ZNF624 ZNF616 ZNF90 ZNF107 ZNF679 ZNF418 ZNF542P PRDM15 ZNF286A ZNF687 ZNF572	3.61e-12	777	150	29	PS00028
Domain	-	ZNF695 ZNF266 ZNF569 ZNF273 ZSCAN26 ZNF300 PRDM5 ZNF354C ZNF551 ZNF260 ZNF248 ZNF461 ZNF12 ZNF26 ZNF33A ZNF33B ZNF846 ZBTB40 ZNF624 ZNF616 ZNF90 ZNF107 ZNF679 ZNF418 PRDM15 ZNF286A ZNF572	5.24e-12	679	150	27	3.30.160.60
Domain	EGF_Lam	ATRN STAB2 LAMA2 LAMA3 LAMA4 LAMC1 MEGF6 ATRNL1 USH2A	6.45e-12	35	150	9	SM00180
Domain	zf-C2H2_6	ZNF695 ZNF266 ZNF569 ZNF273 PRDM5 ZNF354C ZNF551 ZNF260 ZNF461 ZNF12 ZNF26 ZNF846 ZNF624 ZNF616 ZNF90 ZNF107 ZNF418 ZNF286A ZNF572	8.55e-12	314	150	19	PF13912
Domain	Znf_C2H2	ZNF695 ZNF266 ZNF569 ZNF273 ZSCAN26 ZNF300 PRDM5 ZNF354C ZNF551 ZNF260 ZNF248 ZNF461 ZNF12 ZNF26 ZNF33A ZNF33B ZNF846 ZBTB40 ZNF624 ZNF616 ZNF90 ZNF107 ZNF679 ZNF418 ZNF542P PRDM15 ZNF286A ZNF687 ZNF572	8.56e-12	805	150	29	IPR007087
Domain	KRAB	ZNF695 ZNF266 ZNF569 ZNF273 ZNF300 ZNF354C ZNF551 ZNF248 ZNF461 ZNF12 ZNF26 ZNF33A ZNF33B ZNF846 ZNF624 ZNF616 ZNF90 ZNF679 ZNF418 ZNF286A	9.96e-12	358	150	20	PS50805
Domain	Laminin_EGF	ATRN STAB2 LAMA2 LAMA3 LAMA4 LAMC1 MEGF6 ATRNL1 USH2A	1.46e-11	38	150	9	IPR002049
Domain	KRAB	ZNF695 ZNF266 ZNF569 ZNF273 ZNF300 ZNF354C ZNF551 ZNF248 ZNF461 ZNF12 ZNF26 ZNF33A ZNF33B ZNF846 ZNF624 ZNF616 ZNF90 ZNF679 ZNF418 ZNF286A	1.72e-11	369	150	20	SM00349
Domain	KRAB	ZNF695 ZNF266 ZNF569 ZNF273 ZNF300 ZNF354C ZNF551 ZNF248 ZNF461 ZNF12 ZNF26 ZNF33A ZNF33B ZNF846 ZNF624 ZNF616 ZNF90 ZNF679 ZNF418 ZNF286A	1.81e-11	370	150	20	IPR001909
Domain	EGF-like_Ca-bd_dom	VLDLR STAB2 VWCE LRP8 SLIT2 EYS FBN1 EGF MEGF6 SLIT1 ADGRE4P SCUBE3 LTBP2	2.18e-11	124	150	13	IPR001881
Domain	EGF_CA	VLDLR VWCE LRP8 SLIT2 EYS FBN1 EGF MEGF6 SLIT1 ADGRE4P SCUBE3 LTBP2	2.34e-11	99	150	12	PS01187
Domain	EGF-type_Asp/Asn_hydroxyl_site	VLDLR VWCE LRP8 SLIT2 EYS FBN1 EGF MEGF6 SLIT1 ADGRE4P SCUBE3 LTBP2	5.32e-11	106	150	12	IPR000152
Domain	EGF_LAM_2	ATRN STAB2 LAMA2 LAMA3 LAMA4 LAMC1 ATRNL1 USH2A	7.23e-11	30	150	8	PS50027
Domain	EGF_LAM_1	ATRN STAB2 LAMA2 LAMA3 LAMA4 LAMC1 ATRNL1 USH2A	7.23e-11	30	150	8	PS01248
Domain	KRAB	ZNF695 ZNF569 ZNF273 ZNF300 ZNF354C ZNF551 ZNF248 ZNF461 ZNF12 ZNF26 ZNF33A ZNF33B ZNF846 ZNF624 ZNF616 ZNF90 ZNF679 ZNF418 ZNF286A	8.22e-11	358	150	19	PF01352
Domain	EGF_CA	VLDLR STAB2 VWCE LRP8 SLIT2 EYS FBN1 EGF MEGF6 SLIT1 SCUBE3 LTBP2	2.81e-10	122	150	12	SM00179
Domain	EGF_Ca-bd_CS	VLDLR VWCE LRP8 SLIT2 EYS FBN1 EGF MEGF6 SLIT1 SCUBE3 LTBP2	3.41e-10	97	150	11	IPR018097
Domain	EGF	ATRN VLDLR STAB2 LRP8 MEP1B SLIT2 EYS EGF MEGF6 SLIT1 SCUBE3 LTBP2	4.10e-10	126	150	12	PF00008
Domain	ASX_HYDROXYL	VLDLR VWCE LRP8 SLIT2 EYS FBN1 EGF MEGF6 ADGRE4P SCUBE3 LTBP2	4.76e-10	100	150	11	PS00010
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2 LRRC37A LRRC37B	4.00e-09	4	150	4	IPR029423
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2 LRRC37A LRRC37B	4.00e-09	4	150	4	PF14914
Domain	LRRC37_N	LRRC37A3 LRRC37A2 LRRC37A LRRC37B	4.00e-09	4	150	4	IPR032754
Domain	LRRC37	LRRC37A3 LRRC37A2 LRRC37A LRRC37B	4.00e-09	4	150	4	PF15779
Domain	LRRC37A/B-like	LRRC37A3 LRRC37A2 LRRC37A LRRC37B	4.00e-09	4	150	4	IPR015753
Domain	Laminin_EGF	ATRN LAMA2 LAMA3 LAMA4 LAMC1 MEGF6 USH2A	1.04e-08	35	150	7	PF00053
Domain	LAM_G_DOMAIN	LAMA2 LAMA3 LAMA4 SLIT2 EYS SLIT1 USH2A	1.92e-08	38	150	7	PS50025
Domain	Laminin_G	COL19A1 LAMA2 LAMA3 LAMA4 SLIT2 EYS SLIT1 USH2A	1.96e-08	58	150	8	IPR001791
Domain	Laminin_G_2	LAMA2 LAMA3 LAMA4 SLIT2 EYS SLIT1 USH2A	2.80e-08	40	150	7	PF02210
Domain	EGF_CA	VLDLR VWCE LRP8 FBN1 EGF MEGF6 ADGRE4P SCUBE3 LTBP2	2.97e-08	86	150	9	PF07645
Domain	LamG	LAMA2 LAMA3 LAMA4 SLIT2 EYS SLIT1 USH2A	5.59e-08	44	150	7	SM00282
Domain	-	COL19A1 LAMA2 LAMA3 LAMA4 SLIT2 EYS SLIT1 USH2A	9.67e-07	95	150	8	2.60.120.200
Domain	SET	NSD2 NSD1 EZH1 PRDM5 SETDB2 PRDM15	1.74e-06	46	150	6	SM00317
Domain	SET_dom	NSD2 NSD1 EZH1 PRDM5 SETDB2 PRDM15	2.88e-06	50	150	6	IPR001214
Domain	SET	NSD2 NSD1 EZH1 PRDM5 SETDB2 PRDM15	2.88e-06	50	150	6	PS50280
Domain	Laminin_domII	LAMA2 LAMA3 LAMA4	5.02e-06	5	150	3	IPR010307
Domain	Laminin_aI	LAMA2 LAMA3 LAMA4	5.02e-06	5	150	3	IPR009254
Domain	Laminin_I	LAMA2 LAMA3 LAMA4	5.02e-06	5	150	3	PF06008
Domain	Laminin_II	LAMA2 LAMA3 LAMA4	5.02e-06	5	150	3	PF06009
Domain	LY	VLDLR LRP8 EGF ROS1	5.09e-06	15	150	4	SM00135
Domain	LDLR_classB_rpt	VLDLR LRP8 EGF ROS1	5.09e-06	15	150	4	IPR000033
Domain	Laminin_N	LAMA2 LAMA3 LAMC1 USH2A	6.75e-06	16	150	4	IPR008211
Domain	LamNT	LAMA2 LAMA3 LAMC1 USH2A	6.75e-06	16	150	4	SM00136
Domain	LAMININ_NTER	LAMA2 LAMA3 LAMC1 USH2A	6.75e-06	16	150	4	PS51117
Domain	Laminin_N	LAMA2 LAMA3 LAMC1 USH2A	6.75e-06	16	150	4	PF00055
Domain	EGF_extracell	ATRN STAB2 ADAM22 MEGF6 ATRNL1 LTBP2	8.50e-06	60	150	6	IPR013111
Domain	EGF_2	ATRN STAB2 ADAM22 MEGF6 ATRNL1 LTBP2	8.50e-06	60	150	6	PF07974
Domain	LRR_8	LRRC37A3 LRRC37A2 SLITRK1 SLIT2 LRRC37A PXDN SLIT1 LRRC37B PHLPP2	1.01e-05	171	150	9	PF13855
Domain	CTCK_1	VWF SLIT2 SLIT1 MUC2	1.12e-05	18	150	4	PS01185
Domain	ConA-like_dom	COL19A1 LAMA2 LAMA3 LAMA4 MEP1B SLIT2 EYS SLIT1 USH2A RFPL3	1.12e-05	219	150	10	IPR013320
Domain	LRR_TYP	LRRC37A3 LRRC37A2 SLITRK1 SLIT2 LRRC37A PXDN SLIT1 LRRC37B PHLPP2	1.33e-05	177	150	9	SM00369
Domain	Leu-rich_rpt_typical-subtyp	LRRC37A3 LRRC37A2 SLITRK1 SLIT2 LRRC37A PXDN SLIT1 LRRC37B PHLPP2	1.33e-05	177	150	9	IPR003591
Domain	SET	NSD2 NSD1 EZH1 PRDM5 SETDB2	1.86e-05	41	150	5	PF00856
Domain	CT	VWF SLIT2 SLIT1 MUC2	2.61e-05	22	150	4	SM00041
Domain	LAMININ_IVA	LAMA2 LAMA3 LAMC1	2.76e-05	8	150	3	PS51115
Domain	Laminin_B	LAMA2 LAMA3 LAMC1	2.76e-05	8	150	3	PF00052
Domain	LamB	LAMA2 LAMA3 LAMC1	2.76e-05	8	150	3	SM00281
Domain	Laminin_IV	LAMA2 LAMA3 LAMC1	2.76e-05	8	150	3	IPR000034
Domain	Ldl_recept_a	VLDLR TMPRSS6 LRP8 C6 C7	2.95e-05	45	150	5	PF00057
Domain	LRR	LRRC37A3 LRRC37A2 SLITRK1 SLIT2 LRRC37A PXDN SLIT1 LRRC37B PHLPP2	3.63e-05	201	150	9	PS51450
Domain	LDLRA_1	VLDLR TMPRSS6 LRP8 C6 C7	4.05e-05	48	150	5	PS01209
Domain	Cys_knot_C	VWF SLIT2 SLIT1 MUC2	4.43e-05	25	150	4	IPR006207
Domain	CTCK_2	VWF SLIT2 SLIT1 MUC2	4.43e-05	25	150	4	PS01225
Domain	LDrepeatLR_classA_rpt	VLDLR TMPRSS6 LRP8 C6 C7	4.48e-05	49	150	5	IPR002172
Domain	LDLa	VLDLR TMPRSS6 LRP8 C6 C7	4.48e-05	49	150	5	SM00192
Domain	LDLRA_2	VLDLR TMPRSS6 LRP8 C6 C7	4.48e-05	49	150	5	PS50068
Domain	ADAM_Cys-rich	ADAM7 ADAM28 ADAM22 ADAMTS15	6.07e-05	27	150	4	IPR006586
Domain	ACR	ADAM7 ADAM28 ADAM22 ADAMTS15	6.07e-05	27	150	4	SM00608
Domain	Leu-rich_rpt	LRRC37A3 LRRC37A2 NLRP2 SLITRK1 SLIT2 LRRC37A PXDN SLIT1 LRRC37B PHLPP2	6.90e-05	271	150	10	IPR001611
Domain	hEGF	SLIT2 EYS MEGF6 SLIT1	7.04e-05	28	150	4	PF12661
Domain	LRR_1	LRRC37A3 LRRC37A2 SLITRK1 SLIT2 LRRC37A PXDN SLIT1 LRRC37B PHLPP2	7.07e-05	219	150	9	PF00560
Domain	Laminin_G_1	LAMA2 SLIT2 EYS	7.99e-05	11	150	3	PF00054
Domain	Ldl_recept_b	VLDLR LRP8 EGF	1.73e-04	14	150	3	PF00058
Domain	LDLRB	VLDLR LRP8 EGF	1.73e-04	14	150	3	PS51120
Domain	VWFC_1	VWF VWCE PXDN MUC2	1.93e-04	36	150	4	PS01208
Domain	VWFC_2	VWF VWCE PXDN MUC2	2.39e-04	38	150	4	PS50184
Domain	VWC	VWF VWCE PXDN MUC2	2.39e-04	38	150	4	SM00214
Domain	VWF_type-D	VWF VWDE MUC2	2.63e-04	16	150	3	IPR001846
Domain	VWFD	VWF VWDE MUC2	2.63e-04	16	150	3	PS51233
Domain	VWD	VWF VWDE MUC2	2.63e-04	16	150	3	SM00216
Domain	Disintegrin_CS	ADAM7 ADAM28 ADAM22	2.63e-04	16	150	3	IPR018358
Domain	VWD	VWF VWDE MUC2	2.63e-04	16	150	3	PF00094
Domain	Pep_M12B_propep	ADAM7 ADAM28 ADAM22 ADAMTS15	2.64e-04	39	150	4	PF01562
Domain	Peptidase_M12B_N	ADAM7 ADAM28 ADAM22 ADAMTS15	2.64e-04	39	150	4	IPR002870
Domain	-	VLDLR LRP8 EGF ROS1	2.64e-04	39	150	4	2.120.10.30
Domain	-	LRRC37A3 LRRC37A2 NLRP2 SLITRK1 SLIT2 LRRC37A PXDN SLIT1 LRRC37B PHLPP2	2.74e-04	321	150	10	3.80.10.10
Domain	LDLR_class-A_CS	VLDLR LRP8 C6 C7	2.92e-04	40	150	4	IPR023415
Domain	DISINTEGRIN_1	ADAM7 ADAM28 ADAM22 ADAMTS15	2.92e-04	40	150	4	PS00427
Domain	Reprolysin	ADAM7 ADAM28 ADAM22 ADAMTS15	2.92e-04	40	150	4	PF01421
Pathway	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	VWF COL19A1 PDGFA TMPRSS6 LAMA2 LAMA3 LAMA4 LAMC1 FBN1 PXDN FURIN SCUBE3 KDR LTBP2	9.52e-08	300	111	14	M610
Pathway	REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT	CLU C5 C6 C7	2.49e-07	8	111	4	MM14656
Pathway	REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT	CLU C5 C6 C7	2.49e-07	8	111	4	M27006
Pathway	PID_INTEGRIN1_PATHWAY	LAMA2 LAMA3 LAMA4 LAMC1 FBN1 PLAUR	1.29e-05	66	111	6	M18
Pathway	KEGG_MEDICUS_REFERENCE_COMMON_PATHWAY_OF_COMPLEMENT_CASCADE_MAC_FORMATION	C5 C6 C7	1.63e-05	7	111	3	M47873
Pathway	PID_INTEGRIN3_PATHWAY	LAMA4 LAMC1 FBN1 KDR PLAUR	2.10e-05	43	111	5	M53
Pathway	BIOCARTA_ALTERNATIVE_PATHWAY	C5 C6 C7	2.59e-05	8	111	3	MM1582
Pathway	PID_A6B1_A6B4_INTEGRIN_PATHWAY	LAMA2 LAMA3 LAMA4 LAMC1 EGF	2.93e-05	46	111	5	M239
Pathway	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	VWF COL19A1 TMPRSS6 LAMA4 FBN1 PXDN MEGF6 FURIN SCUBE3 LTBP2	3.61e-05	258	111	10	MM14572
Pathway	BIOCARTA_ALTERNATIVE_PATHWAY	C5 C6 C7	3.86e-05	9	111	3	M22072
Pathway	KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_MAC_INHIBITION	CLU C6 C7	3.86e-05	9	111	3	M47881
Pathway	BIOCARTA_LECTIN_PATHWAY	C5 C6 C7	7.49e-05	11	111	3	MM1430
Pathway	PID_INTEGRIN4_PATHWAY	LAMA2 LAMA3 LAMC1	7.49e-05	11	111	3	M158
Pathway	REACTOME_MET_ACTIVATES_PTK2_SIGNALING	LAMA2 LAMA3 LAMA4 LAMC1	8.52e-05	30	111	4	M27772
Pathway	REACTOME_LAMININ_INTERACTIONS	LAMA2 LAMA3 LAMA4 LAMC1	8.52e-05	30	111	4	M27216
Pathway	WP_COMPLEMENT_AND_COAGULATION_CASCADES	VWF CLU PLAUR C6 C7	9.09e-05	58	111	5	M39649
Pathway	WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES	VWF CLU PLAUR C6 C7	9.87e-05	59	111	5	M48343
Pathway	REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS	PDGFA LAMA2 LAMA3 LAMA4 LAMC1	9.87e-05	59	111	5	M27218
Pathway	BIOCARTA_CLASSIC_PATHWAY	C5 C6 C7	9.93e-05	12	111	3	MM1368
Pathway	WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY	C5 C6 C7	9.93e-05	12	111	3	M48316
Pathway	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	COL19A1 TMPRSS6 LAMA3 LAMC1 FBN1 FURIN SCUBE3	1.18e-04	140	111	7	M587
Pathway	BIOCARTA_LECTIN_PATHWAY	C5 C6 C7	1.28e-04	13	111	3	M4732
Pathway	KEGG_PRION_DISEASES	LAMC1 C5 C6 C7	1.58e-04	35	111	4	M13036
Pathway	WP_FOCAL_ADHESION	VWF PDGFA LAMA2 LAMA3 LAMA4 LAMC1 EGF KDR	1.75e-04	199	111	8	M39402
Pathway	KEGG_FOCAL_ADHESION	VWF PDGFA LAMA2 LAMA3 LAMA4 LAMC1 EGF KDR	1.75e-04	199	111	8	M7253
Pathway	BIOCARTA_CLASSIC_PATHWAY	C5 C6 C7	2.02e-04	15	111	3	M7146
Pathway	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	VWF PLAUR C5 C6 C7	2.08e-04	69	111	5	M16894
Pathway	WP_COMPREHENSIVE_IL17A_SIGNALING	PDGFA MCM3 FBN1 PLAUR CCL18 C7	2.29e-04	110	111	6	MM16642
Pathway	WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY	VWF PDGFA LAMA2 LAMA3 LAMA4 LAMC1 IFNA5 EGF KDR PHLPP2	2.49e-04	326	111	10	MM15917
Pathway	REACTOME_MET_PROMOTES_CELL_MOTILITY	LAMA2 LAMA3 LAMA4 LAMC1	2.95e-04	41	111	4	M27778
Pathway	WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE	C5 C6 C7	2.98e-04	17	111	3	M39733
Pathway	WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY	C5 C6 C7	2.98e-04	17	111	3	MM15944
Pathway	BIOCARTA_LAIR_PATHWAY	C5 C6 C7	2.98e-04	17	111	3	M3952
Pathway	BIOCARTA_COMP_PATHWAY	C5 C6 C7	2.98e-04	17	111	3	MM1369
Pathway	WP_PI3KAKT_SIGNALING	VWF PDGFA LAMA2 LAMA3 LAMA4 LAMC1 IFNA5 EGF KDR PHLPP2	3.40e-04	339	111	10	M39736
Pathway	BIOCARTA_COMP_PATHWAY	C5 C6 C7	4.91e-04	20	111	3	M917
Pathway	KEGG_ECM_RECEPTOR_INTERACTION	VWF LAMA2 LAMA3 LAMA4 LAMC1	5.21e-04	84	111	5	M7098
Pathway	WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1	FURIN KDR	6.05e-04	5	111	2	M42561
Pathway	WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING	VWF PDGFA LAMA2 LAMA3 LAMA4 LAMC1 EGF KDR PHLPP2	6.31e-04	302	111	9	M39719
Pathway	WP_COMPLEMENT_ACTIVATION	C5 C6 C7	6.56e-04	22	111	3	M39502
Pathway	WP_FOCAL_ADHESION	VWF PDGFA LAMA2 LAMA3 LAMA4 LAMC1 EGF	6.87e-04	187	111	7	MM15913
Pathway	WP_ROBO4_AND_VEGF_SIGNALING_PATHWAYS_CROSSTALK	SLIT2 KDR	9.03e-04	6	111	2	MM15933
Pathway	WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK	SLIT2 KDR	9.03e-04	6	111	2	M39486
Pathway	WP_COMPLEMENT_SYSTEM	LAMC1 PLAUR C5 C6 C7	9.57e-04	96	111	5	M39581
Pathway	WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE	POSTN FBN1 LTBP2	9.63e-04	25	111	3	M39713
Pathway	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY	ZNF695 ZNF569 RNF34 ZNF300 KAT2A ZNF354C ZNF551 ZNF248 ZNF12 FURIN ZNF624 ZNF616 ZNF107 ZNF418 ZNF286A	9.90e-04	768	111	15	MM14851
Pathway	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	ZNF266 ZNF569 ZNF273 RNF34 ZNF300 NCBP1 KAT2A FAS ZNF354C ZNF551 ZNF248 ZNF461 ZNF12 ZNF26 ZNF33A ZNF33B FURIN ZNF624 ZNF616 ZNF679 ZNF418 ZNF286A	1.06e-03	1387	111	22	M734
Pathway	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	PDGFA TNFRSF17 FAS IFNA5 EGF KDR CCL18 TNFRSF1A	1.14e-03	264	111	8	M9809
Pathway	BIOCARTA_REELIN_PATHWAY	VLDLR LRP8	1.26e-03	7	111	2	MM1566
Pathway	BIOCARTA_REELIN_PATHWAY	VLDLR LRP8	1.26e-03	7	111	2	M22049
Pathway	WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY	FAS CLU C5 C6 C7	1.49e-03	106	111	5	M42535
Pathway	BIOCARTA_AGR_PATHWAY	LAMA2 LAMA3 LAMA4	1.82e-03	31	111	3	MM1343
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	VWF LAMA2 LAMA3 LAMA4 LAMC1 POSTN SLIT2 FBN1 PXDN MEGF6 LTBP2	4.41e-10	175	155	11	28071719
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	VWF LAMA2 LAMA3 LAMA4 LAMC1 POSTN FBN1 PXDN LTBP2 MUC2	4.48e-09	167	155	10	22159717
Pubmed	Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.	VWF LAMA2 LAMA4 LAMC1 POSTN SLIT2 FBN1 PXDN CLU SMPDL3A LTBP2	1.70e-08	248	155	11	24006456
Pubmed	Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.	VWF LAMA2 LAMA3 LAMA4 LAMC1 POSTN FBN1 CLU LTBP2	2.11e-08	146	155	9	27068509
Pubmed	Roles for laminin in embryogenesis: exencephaly, syndactyly, and placentopathy in mice lacking the laminin alpha5 chain.	LAMA2 LAMA3 LAMA4 LAMC1	2.62e-08	8	155	4	9852162
Pubmed	Evolutionary dynamism of the primate LRRC37 gene family.	LRRC37A3 LRRC37A2 LRRC37A LRRC37B	7.80e-08	10	155	4	23064749
Pubmed	Distribution of the ten known laminin chains in the pathways and targets of developing sensory axons.	LAMA2 LAMA3 LAMA4 LAMC1	7.80e-08	10	155	4	9034910
Pubmed	Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR.	ZNF695 ZNF569 ZNF300 ZNF624 ZNF616 ZNF107	8.49e-08	49	155	6	9630514
Pubmed	Formation and structure of the C5b-7 complex of the lytic pathway of complement.	C5 C6 C7	8.68e-08	3	155	3	1387399
Pubmed	Laminin alpha 5 is required for lobar septation and visceral pleural basement membrane formation in the developing mouse lung.	LAMA2 LAMA3 LAMA4 LAMC1	1.22e-07	11	155	4	12051813
Pubmed	Regional differences in the expression of laminin isoforms during mouse neural tube development.	LAMA2 LAMA3 LAMA4 LAMC1	1.22e-07	11	155	4	21524702
Pubmed	Molecular dissection of laminin alpha 5 in vivo reveals separable domain-specific roles in embryonic development and kidney function.	LAMA2 LAMA3 LAMA4 LAMC1	1.83e-07	12	155	4	16750824
Pubmed	Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice.	LAMA2 LAMA3 LAMA4 LAMC1	1.83e-07	12	155	4	9396756
Pubmed	Fukutin-related protein alters the deposition of laminin in the eye and brain.	LAMA2 LAMA3 LAMA4 LAMC1	2.63e-07	13	155	4	21900571
Pubmed	Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation.	LAMA2 LAMA4 LAMC1 POSTN FBN1 CLU LTBP2	2.80e-07	97	155	7	27559042
Pubmed	Clusterin is a ligand for apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR) and signals via the Reelin-signaling pathway.	VLDLR LRP8 CLU	3.46e-07	4	155	3	24381170
Pubmed	Exposure to the complement C5b-9 complex sensitizes 661W photoreceptor cells to both apoptosis and necroptosis.	C5 C6 C7	3.46e-07	4	155	3	25735751
Pubmed	Primate segmental duplication creates novel promoters for the LRRC37 gene family within the 17q21.31 inversion polymorphism region.	LRRC37A3 LRRC37A2 LRRC37A	3.46e-07	4	155	3	22419166
Pubmed	The laminin alpha chains: expression, developmental transitions, and chromosomal locations of alpha1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel alpha3 isoform.	LAMA2 LAMA3 LAMA4 ROS1	3.67e-07	14	155	4	9151674
Pubmed	Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.	VWF COL19A1 LAMA2 LAMA4 LAMC1 POSTN FBN1 MUC2	4.65e-07	153	155	8	25037231
Pubmed	Basement membrane composition in the early mouse embryo day 7.	LAMA2 LAMA3 LAMA4 LAMC1	4.99e-07	15	155	4	15895400
Pubmed	Laminin alpha5 is necessary for submandibular gland epithelial morphogenesis and influences FGFR expression through beta1 integrin signaling.	LAMA2 LAMA3 LAMA4 LAMC1	6.62e-07	16	155	4	17601529
Pubmed	Differential expression of laminin alpha chains during murine tooth development.	LAMA2 LAMA3 LAMA4	8.63e-07	5	155	3	9389447
Pubmed	Expression and distribution of laminin alpha1 and alpha2 chains in embryonic and adult mouse tissues: an immunochemical approach.	LAMA2 LAMA3 LAMC1	8.63e-07	5	155	3	11969289
Pubmed	Differential expression of five laminin alpha (1-5) chains in developing and adult mouse kidney.	LAMA2 LAMA3 LAMA4	8.63e-07	5	155	3	9415429
Pubmed	Thyroid follicle development requires Smad1/5- and endothelial cell-dependent basement membrane assembly.	LAMA2 LAMA3 LAMA4 LAMC1 KDR	9.56e-07	40	155	5	27068110
Pubmed	Amplification of extracellular matrix and oncogenes in tat-transfected human salivary gland cell lines with expression of laminin, fibronectin, collagens I, III, IV, c-myc and p53.	LAMA2 LAMA3 LAMA4 LAMC1	1.11e-06	18	155	4	11311202
Pubmed	Robo1 regulates semaphorin signaling to guide the migration of cortical interneurons through the ventral forebrain.	LHX8 SLIT2 SLIT1 KDR	1.40e-06	19	155	4	21508241
Pubmed	HIV-protein-mediated alterations in T cell interactions with the extracellular matrix proteins and endothelium.	LAMA2 LAMA3 LAMA4	1.72e-06	6	155	3	9597096
Pubmed	A model for modulation of leptin activity by association with clusterin.	VLDLR LRP8 CLU	1.72e-06	6	155	3	12824284
Pubmed	Assembly and regulation of the membrane attack complex based on structures of C5b6 and sC5b9.	C5 C6 C7	1.72e-06	6	155	3	22832194
Pubmed	Exploring functional candidate genes for genetic association in german patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma.	FBN1 CLU LTBP2	1.72e-06	6	155	3	19182256
Pubmed	Laminin and integrin expression in the ventral ectodermal ridge of the mouse embryo: implications for regulation of BMP signalling.	LAMA2 LAMA3 LAMA4 LAMC1	1.74e-06	20	155	4	22911573
Pubmed	Isolation of cDNA clones for 42 different Krüppel-related zinc finger proteins expressed in the human monoblast cell line U-937.	ZNF266 ZNF273 ZNF461 ZNF12	2.14e-06	21	155	4	7865130
Pubmed	A new nomenclature for the laminins.	LAMA3 LAMA4 LAMC1	3.00e-06	7	155	3	7921537
Pubmed	Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death.	C5 C6 C7	3.00e-06	7	155	3	19864026
Pubmed	CryoEM reveals how the complement membrane attack complex ruptures lipid bilayers.	C5 C6 C7	3.00e-06	7	155	3	30552328
Pubmed	Laminin isoforms in fetal and adult human adrenal cortex.	LAMA2 LAMA4 LAMC1	3.00e-06	7	155	3	14557481
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ATRN DCAF6 EPHA6 NSD2 TMPRSS6 PSCA LAMA3 DYNC2I1 DGKH WNT4 ZNF248 ZNF461 LRP8 PXDN ZNF33A ZNF33B MEGF6 FNIP1 ZNF107 PRDM15 TET3	3.12e-06	1489	155	21	28611215
Pubmed	Cloning and expression analyses of mouse dystroglycan gene: specific expression in maternal decidua at the peri-implantation stage.	LAMA2 LAMA3 LAMC1	4.78e-06	8	155	3	8872465
Pubmed	Molecular organization and function of the complement system.	C5 C6 C7	4.78e-06	8	155	3	3052276
Pubmed	Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins.	LAMA2 LAMA3 LAMA4 LAMC1	5.26e-06	26	155	4	24742657
Pubmed	Sequential use of transcriptional profiling, expression quantitative trait mapping, and gene association implicates MMP20 in human kidney aging.	LAMA3 LAMC1 POSTN EGF LPL C7	5.34e-06	98	155	6	19834535
Pubmed	Microfibril-associated glycoprotein-2 interacts with fibrillin-1 and fibrillin-2 suggesting a role for MAGP-2 in elastic fiber assembly.	VWF FBN1 MEGF6	7.15e-06	9	155	3	12122015
Pubmed	Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance.	VLDLR LRP8 CLU	7.15e-06	9	155	3	20005821
Pubmed	Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells.	C5 C6 C7	7.15e-06	9	155	3	19162005
Pubmed	Complement Inhibitor CRIg/FH Ameliorates Renal Ischemia Reperfusion Injury via Activation of PI3K/AKT Signaling.	FBN1 C5 C6	1.02e-05	10	155	3	30429287
Pubmed	Integrin-laminin interactions controlling neurite outgrowth from adult DRG neurons in vitro.	LAMA2 LAMA4 LAMC1	1.02e-05	10	155	3	18590826
Pubmed	Trophoblast-specific expression and function of the integrin alpha 7 subunit in the peri-implantation mouse embryo.	LAMA2 LAMA4 LAMC1	1.02e-05	10	155	3	11784026
Pubmed	Risk of non-Hodgkin lymphoma in association with germline variation in complement genes.	CLU C5 C6 C7	1.09e-05	31	155	4	19344414
Pubmed	Multiple genes encoding zinc finger domains are expressed in human T cells.	ZNF551 ZNF12 ZNF26 ZNF33B	1.09e-05	31	155	4	2288909
Pubmed	Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities.	LAMA2 LAMA4 LAMC1	1.40e-05	11	155	3	23472759
Pubmed	Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.	ZNF569 ZNF273 ZNF33A ZNF33B ZNF624 ZNF90 ZNF107	1.79e-05	181	155	7	37372979
Pubmed	Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis.	LAMA2 LAMA4 KDR	1.85e-05	12	155	3	11381080
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	PDS5B JADE3 NSD2 LIN54 ZSCAN26 NSD1 NCBP1 ZNF12 SETDB2 ZBTB40 PRDM15 ZMYM3	1.97e-05	608	155	12	36089195
Pubmed	Complete primary structure and functional characterization of the sixth component of the human complement system. Identification of the C5b-binding domain in complement C6.	C5 C6	1.97e-05	2	155	2	2808363
Pubmed	Preferred sequence requirements for cleavage of pro-von Willebrand factor by propeptide-processing enzymes.	VWF FURIN	1.97e-05	2	155	2	1571548
Pubmed	Identification and characterization of two splice variants of human diacylglycerol kinase eta.	DGKD DGKH	1.97e-05	2	155	2	12810723
Pubmed	SNAP23 Regulates Endothelial Exocytosis of von Willebrand Factor.	VWF SNAP23	1.97e-05	2	155	2	26266817
Pubmed	Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency.	VLDLR LPL	1.97e-05	2	155	2	11790777
Pubmed	The reelin receptors VLDLR and ApoER2 regulate sensorimotor gating in mice.	VLDLR LRP8	1.97e-05	2	155	2	17261317
Pubmed	Complement components C5 and C7: recombinant factor I modules of C7 bind to the C345C domain of C5.	C5 C7	1.97e-05	2	155	2	15383587
Pubmed	[Relationship between myocardial modelling and diastolic function in patients with essential hypertension].	FAS TNFRSF1A	1.97e-05	2	155	2	22036455
Pubmed	EGF inhibits expression of WDNM1 and sulfated glycoprotein-2 genes in mammary epithelial cells.	EGF CLU	1.97e-05	2	155	2	9367891
Pubmed	Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression.	POSTN KDR	1.97e-05	2	155	2	15082792
Pubmed	The proteolytic processing of pro-platelet-derived growth factor-A at RRKR(86) by members of the proprotein convertase family is functionally correlated to platelet-derived growth factor-A-induced functions and tumorigenicity.	PDGFA FURIN	1.97e-05	2	155	2	12670890
Pubmed	Linkage between complement components 6 and 7 and glutamic pyruvate transaminase in the marsupial Monodelphis domestica.	C6 C7	1.97e-05	2	155	2	8259924
Pubmed	Genetic analysis of osteoblast activity identifies Zbtb40 as a regulator of osteoblast activity and bone mass.	WNT4 ZBTB40	1.97e-05	2	155	2	32497039
Pubmed	Neutrophils activated by membrane attack complexes increase the permeability of melanoma blood vessels.	C5 C6	1.97e-05	2	155	2	35960843
Pubmed	A physical map of the C6 and C7 complement component gene region on chromosome 5p13.	C6 C7	1.97e-05	2	155	2	8364540
Pubmed	Macromolecular organization of basement membranes.	LAMA2 LAMA3	1.97e-05	2	155	2	8939648
Pubmed	Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism.	VLDLR LPL	1.97e-05	2	155	2	18375436
Pubmed	Expression of a human proprotein processing enzyme: correct cleavage of the von Willebrand factor precursor at a paired basic amino acid site.	VWF FURIN	1.97e-05	2	155	2	2251280
Pubmed	Activation of the epithelial sodium channel by the metalloprotease meprin β subunit.	MEP1B SCNN1G	1.97e-05	2	155	2	20953144
Pubmed	The complete cDNA sequence and structural polymorphism of the polypeptide chain of porcine submaxillary mucin.	VWF MUC2	1.97e-05	2	155	2	9407109
Pubmed	Reduced level of epidermal growth factor in the skeletal muscle of mice with muscular dystrophy.	LAMA2 EGF	1.97e-05	2	155	2	1577403
Pubmed	Apoptosis mediated by Fas but not tumor necrosis factor receptor 1 prevents chronic disease in mice infected with murine cytomegalovirus.	FAS TNFRSF1A	1.97e-05	2	155	2	9769336
Pubmed	Slit2 Promotes Angiogenic Activity Via the Robo1-VEGFR2-ERK1/2 Pathway in Both In Vivo and In Vitro Studies.	SLIT2 KDR	1.97e-05	2	155	2	26244297
Pubmed	Molecular, biochemical, and cellular characterization of epididymal ADAMs, ADAM7 and ADAM28.	ADAM7 ADAM28	1.97e-05	2	155	2	15883027
Pubmed	Greatly accelerated lymphadenopathy and autoimmune disease in lpr mice lacking tumor necrosis factor receptor I.	FAS TNFRSF1A	1.97e-05	2	155	2	8609380
Pubmed	Coordinate control of axon defasciculation and myelination by laminin-2 and -8.	LAMA2 LAMA4	1.97e-05	2	155	2	15699217
Pubmed	Fas bridging cell death and cytotoxicity: the reaper connection.	FAS TNFRSF1A	1.97e-05	2	155	2	7493759
Pubmed	Slit1 and slit2 proteins control the development of the lateral olfactory tract.	SLIT2 SLIT1	1.97e-05	2	155	2	12097499
Pubmed	VLDLR and ApoER2 are receptors for multiple alphaviruses.	VLDLR LRP8	1.97e-05	2	155	2	34929721
Pubmed	Genetic analysis of attractin homologs.	ATRN ATRNL1	1.97e-05	2	155	2	18064672
Pubmed	Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome.	GTF2IRD2B GTF2IRD2	1.97e-05	2	155	2	15388857
Pubmed	Involvement of β-defensin 130 (DEFB130) in the macrophage microbicidal mechanisms for killing Plasmodium falciparum.	DEFB130B DEFB130A	1.97e-05	2	155	2	28181499
Pubmed	TNF receptor 1 (TNFR1) and CD95 are not required for T cell deletion after virus infection but contribute to peptide-induced deletion under limited conditions.	FAS TNFRSF1A	1.97e-05	2	155	2	10671227
Pubmed	Homology between reaper and the cell death domains of Fas and TNFR1.	FAS TNFRSF1A	1.97e-05	2	155	2	7537635
Pubmed	Clonidine Induces Apoptosis of Human Corneal Epithelial Cells through Death Receptors-Mediated, Mitochondria-Dependent Signaling Pathway.	FAS TNFRSF1A	1.97e-05	2	155	2	28115640
Pubmed	Partial USH2A deletions contribute to Usher syndrome in Denmark.	PCDH15 USH2A	1.97e-05	2	155	2	25804404
Pubmed	Various Forms of Programmed Cell Death Are Concurrently Activated in the Population of Retinal Ganglion Cells after Ischemia and Reperfusion.	FAS TNFRSF1A	1.97e-05	2	155	2	37373037
Pubmed	Autoimmune kidney disease and lymphadenopathy in NODlpr mice are not modified by deficiency in tumor necrosis factor receptor 1 or beta 2-microglobulin.	FAS TNFRSF1A	1.97e-05	2	155	2	12750352
Pubmed	NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis.	NSD2 NSD1	1.97e-05	2	155	2	29176703
Pubmed	Two human genes encoding zinc finger proteins, ZNF 12 (KOX 3) and ZNF 26 (KOX 20), map to chromosome 7p22-p21 and 12q24.33, respectively.	ZNF12 ZNF26	1.97e-05	2	155	2	2026422
Pubmed	EGF-induced urokinase plasminogen activator receptor promotes epithelial to mesenchymal transition in human gastric cancer cells.	EGF PLAUR	1.97e-05	2	155	2	28849196
Pubmed	Apoptotic mechanisms in fulminant hepatic failure: potential therapeutic target.	FAS TNFRSF1A	1.97e-05	2	155	2	19077906
Pubmed	ApoER2 and VLDLR in the developing human telencephalon.	VLDLR LRP8	1.97e-05	2	155	2	21601501
Pubmed	Diacylglycerol kinase δ modulates Akt phosphorylation through pleckstrin homology domain leucine-rich repeat protein phosphatase 2 (PHLPP2).	DGKD PHLPP2	1.97e-05	2	155	2	23184957
Pubmed	Cloning of the LamA3 gene encoding the alpha 3 chain of the adhesive ligand epiligrin. Expression in wound repair.	LAMA3 LAMA4	1.97e-05	2	155	2	8077230
Interaction	MANEA interactions	ATRN LAMA4 LAMC1 CLU ADGRE4P PLAUR	5.32e-06	60	149	6	int:MANEA
Cytoband	10p11.2	ZNF248 ZNF33A	3.17e-04	8	156	2	10p11.2
Cytoband	9p24	VLDLR INSL6	3.17e-04	8	156	2	9p24
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF695 ZNF266 ZNF569 ZNF273 ZSCAN26 ZNF300 PRDM5 ZNF354C ZNF551 ZNF260 ZNF248 ZNF461 ZNF12 ZNF26 ZNF33A ZNF33B ZNF846 ZBTB40 ZNF624 ZNF616 ZNF90 ZNF107 ZNF679 ZNF418 ZNF542P PRDM15 ZNF286A ZNF572	2.28e-15	718	111	28	28
GeneFamily	Laminin subunits	LAMA2 LAMA3 LAMA4 LAMC1	6.41e-07	12	111	4	626
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	NSD2 NSD1 EZH1 SETDB2	5.41e-05	34	111	4	487
GeneFamily	Zinc fingers MYM-type	ZMYM1 ZMYM3	5.51e-04	6	111	2	86
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	ADAM7 ADAM28 ADAM22	5.92e-04	27	111	3	47
GeneFamily	CD molecules\|Tumor necrosis factor receptor superfamily\|Death inducing signaling complex	TNFRSF17 FAS TNFRSF1A	7.33e-04	29	111	3	782
GeneFamily	Complement system\|Sushi domain containing	C5 C6 C7	1.39e-03	36	111	3	492
GeneFamily	EF-hand domain containing\|Diacylglycerol kinases	DGKD DGKH	1.63e-03	10	111	2	1178
GeneFamily	Low density lipoprotein receptors	VLDLR LRP8	2.79e-03	13	111	2	634
GeneFamily	Zinc fingers C2H2-type\|PR/SET domain family	PRDM5 PRDM15	4.78e-03	17	111	2	1197
GeneFamily	WD repeat domain containing\|DDB1 and CUL4 associated factors	DCAF6 DTL	5.36e-03	18	111	2	498
Coexpression	NABA_MATRISOME	VWF COL19A1 PDGFA ADAM7 LAMA2 LAMA3 LAMA4 LAMC1 WNT4 VWCE VWDE ADAM28 ADAM22 IFNA5 EGFEM1P MEP1B POSTN SLIT2 FBN1 PXDN EGF MEGF6 INSL6 OTOGL SLIT1 ADAMTS15 SCUBE3 LTBP2 CCL18 MUC2 RSPO1	1.99e-14	1008	152	31	MM17056
Coexpression	NABA_ECM_GLYCOPROTEINS	VWF LAMA2 LAMA3 LAMA4 LAMC1 VWCE VWDE EGFEM1P POSTN SLIT2 FBN1 PXDN OTOGL SLIT1 LTBP2 RSPO1	2.42e-14	191	152	16	MM17059
Coexpression	NABA_MATRISOME	VWF COL19A1 PDGFA ADAM7 LAMA2 LAMA3 LAMA4 LAMC1 WNT4 VWCE VWDE ADAM28 ADAM22 IFNA5 MEP1B POSTN SLIT2 EYS FBN1 PXDN EGF MEGF6 INSL6 SLIT1 ADAMTS15 SCUBE3 LTBP2 CCL18 MUC2 USH2A RSPO1	3.20e-14	1026	152	31	M5889
Coexpression	NABA_ECM_GLYCOPROTEINS	VWF LAMA2 LAMA3 LAMA4 LAMC1 VWCE VWDE POSTN SLIT2 EYS FBN1 PXDN SLIT1 LTBP2 USH2A RSPO1	3.63e-14	196	152	16	M3008
Coexpression	NABA_CORE_MATRISOME	VWF COL19A1 LAMA2 LAMA3 LAMA4 LAMC1 VWCE VWDE EGFEM1P POSTN SLIT2 FBN1 PXDN OTOGL SLIT1 LTBP2 RSPO1	3.96e-13	270	152	17	MM17057
Coexpression	NABA_CORE_MATRISOME	VWF COL19A1 LAMA2 LAMA3 LAMA4 LAMC1 VWCE VWDE POSTN SLIT2 EYS FBN1 PXDN SLIT1 LTBP2 USH2A RSPO1	5.32e-13	275	152	17	M5884
Coexpression	NABA_BASEMENT_MEMBRANES	LAMA2 LAMA3 LAMA4 LAMC1 USH2A	3.43e-06	40	152	5	M5887
Coexpression	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	DTL LAMC1 FAS ADAM22 ZNF260 POSTN IFIH1 FBN1 TWSG1 ZNF286A	1.23e-05	305	152	10	M19875
Coexpression	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	LAMA2 LAMA3 LAMC1 FAS POSTN SLIT2 FBN1 PLAUR	2.29e-05	200	152	8	M5930
Coexpression	TRAVAGLINI_LUNG_LYMPHATIC_CELL	STAB2 PDGFA LAMA4 LAMC1 PKHD1L1 DIPK2B MEGF6 CLU	3.14e-05	209	152	8	M41670
Coexpression	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP	WNT4 PLAUR LTBP2	5.24e-05	13	152	3	M17359
Coexpression	VECCHI_GASTRIC_CANCER_EARLY_DN	VLDLR TMPRSS6 LAMA2 TNFRSF17 CLDN10 MEP1B SLIT2 CLU C6 C7	8.24e-05	382	152	10	M15472
Coexpression	NABA_MATRISOME_ASSOCIATED	PDGFA ADAM7 WNT4 ADAM28 ADAM22 IFNA5 MEP1B EGF MEGF6 INSL6 ADAMTS15 SCUBE3 CCL18 MUC2	1.06e-04	738	152	14	MM17058
Coexpression	DESCARTES_FETAL_THYMUS_VASCULAR_ENDOTHELIAL_CELLS	STAB2 VWF PKHD1L1 DIPK2B EGF KDR	1.19e-04	131	152	6	M40316
Coexpression	CUI_DEVELOPING_HEART_5TH_WEEK_ATRIAL_CARDIOMYOCYTE	LAMA4 SLIT2 SCUBE3 C7	1.23e-04	44	152	4	M39311
Coexpression	NABA_MATRISOME_ASSOCIATED	PDGFA ADAM7 WNT4 ADAM28 ADAM22 IFNA5 MEP1B EGF MEGF6 INSL6 ADAMTS15 SCUBE3 CCL18 MUC2	1.27e-04	751	152	14	M5885
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	PDS5B ATRN VLDLR RANBP2 SLIT2	1.39e-04	85	152	5	M10575
Coexpression	GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_UP	ATRN LRRC37A3 ZSCAN26 EZH1 SPATA2 NLRP2 ATP2C2	1.52e-04	196	152	7	M8161
Coexpression	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP	DTL DGKH POSTN FBN1	1.60e-04	47	152	4	M7585
Coexpression	GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN	IFIH1 FBN1 ZNF33B AFP SNX7 SCUBE3 RFPL3	1.62e-04	198	152	7	M7261
Coexpression	GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN	PDYN DTL DGKH FAS MANSC1 SMPDL3A FURIN	1.67e-04	199	152	7	M9256
Coexpression	GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_UP	ATRN VLDLR DCAF6 ZNF266 EPHA6 TNFRSF17 ATRNL1	1.72e-04	200	152	7	M7335
Coexpression	HEVNER_CORTEX_VASCULAR_ENDOTHELIAL_CELLS	VWF LAMA4 KDR	1.73e-04	19	152	3	MM420
Coexpression	GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS	VWF TRPC1 LAMA4 LAMC1 TNS2 ADAM28 POSTN FBN1 PXDN LTBP2 ZNF687	1.84e-04	505	152	11	M39167
CoexpressionAtlas	kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500	PDGFA LAMA4 LAMC1 WNT4 SLIT2 DDIAS SCUBE3 NEIL3	1.05e-05	148	150	8	gudmap_kidney_P3_CapMes_Crym_k2_500
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL19A1 TMPRSS6 PKHD1L1 ADAM28 OTOGL PCDH15 LTBP2 C6 USH2A	8.44e-09	169	155	9	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA1D LAMA2 LAMA4 FAS SLIT2 SMPDL3A SLIT1 PCDH15 C7	2.23e-08	189	155	9	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1D LAMA2 LAMA4 LAMC1 SLIT2 FBN1 PCDH15 LTBP2 C7	2.44e-08	191	155	9	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1D LAMA2 LAMA4 LAMC1 SLIT2 FBN1 PCDH15 LTBP2 C7	2.56e-08	192	155	9	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	VWF LAMA2 LAMC1 POSTN SLIT2 FBN1 PXDN LTBP2 C7	2.56e-08	192	155	9	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNA1D LAMA2 LAMA4 LAMC1 SLIT2 FBN1 ADAMTS15 TWSG1 C7	2.67e-08	193	155	9	4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNA1D LAMA2 LAMA4 LAMC1 SLIT2 FBN1 ADAMTS15 TWSG1 C7	2.67e-08	193	155	9	ff8ceeb3cfd1bef7239df490c19d181091750833
ToppCell	21-Trachea-Mesenchymal-Mesenchyme_RSPO2+\|Trachea / Age, Tissue, Lineage and Cell class	CACNA1D LAMA2 LAMA4 POSTN SLIT2 FBN1 SMPDL3A LPL C7	2.79e-08	194	155	9	8fc98d2c9d94f3bc6292265e20ab71c4f1f37bb3
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CACNA1D LAMA2 LAMA4 LAMC1 SLIT2 FBN1 PCDH15 LTBP2 C7	2.92e-08	195	155	9	df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	CACNA1D LAMA2 LAMA4 LAMC1 SLIT2 FBN1 PCDH15 LTBP2 C7	2.92e-08	195	155	9	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	CACNA1D LAMA2 LAMA4 LAMC1 SLIT2 FBN1 PCDH15 LTBP2 C7	2.92e-08	195	155	9	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CACNA1D LAMA2 LAMA4 LAMC1 SLIT2 FBN1 PCDH15 LTBP2 C7	2.92e-08	195	155	9	4243190ad291d56694e2155954dbaa879c9d3844
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1D LAMA2 LAMA4 LAMC1 SLIT2 FBN1 PCDH15 ADAMTS15 C7	3.05e-08	196	155	9	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1D LAMA2 LAMA4 LAMC1 SLIT2 FBN1 PCDH15 LTBP2 C7	3.05e-08	196	155	9	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1D LAMA2 LAMA4 LAMC1 SLIT2 FBN1 PCDH15 LTBP2 C7	3.33e-08	198	155	9	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1D LAMA2 LAMA4 LAMC1 SLIT2 FBN1 LTBP2 C7 RSPO1	3.33e-08	198	155	9	f1374f7a50244d59c766ac41f44c08c9117407d2
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1D LAMA2 LAMA4 LAMC1 SLIT2 FBN1 LTBP2 C7 RSPO1	3.48e-08	199	155	9	66a79732caf2f04c09b4d9832377aa01ca477677
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA2 LAMA4 TNS2 WNT4 ADAM28 POSTN FBN1 PXDN	1.44e-07	169	155	8	c0824a93674e2bff0f09b2d2fab5bab016a2e379
ToppCell	E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CACNA1D VLDLR VWF SLIT2 FBN1 INSL6 KDR PRR14L	1.51e-07	170	155	8	7fa022471e14ac8a3bc147c793368a4d56a8e591
ToppCell	Basal_cells-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	DGKH CLDN10 ADAM28 SLC22A18AS CLU SCNN1G ZNF418 ZNF286A	1.51e-07	170	155	8	776d4224a682b6c648041827efd69794f88906f0
ToppCell	Nasal_Brush-Epithelial-Ionocytes\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	VWF LAMA4 POSTN PXDN SMPDL3A SCNN1G ZNF624 LTBP2	1.65e-07	172	155	8	04fabb40fa9357d8902f3b04adc15231626cd9f8
ToppCell	Nasal_Brush-Epithelial-Ionocytes\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	VWF LAMA4 POSTN PXDN SMPDL3A SCNN1G ZNF624 LTBP2	1.65e-07	172	155	8	dd3a23dc78dc6939f41126f8d7bd23a2e4713647
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1D LAMA2 LAMA4 LAMC1 SLIT2 FBN1 PCDH15 C7	2.44e-07	181	155	8	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1D LAMC1 PRDM5 SLIT2 FBN1 ADAMTS15 TWSG1 C7	2.55e-07	182	155	8	c557de6ccd327c46e0a5423cd9936d78e0abae5f
ToppCell	facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1D LAMC1 PRDM5 SLIT2 FBN1 ADAMTS15 TWSG1 C7	2.55e-07	182	155	8	dbe4b2557cf19e0682ed446f8397d3a1153642f0
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	VWF LAMA2 LAMC1 DIPK2B FBN1 PXDN LTBP2 C7	2.55e-07	182	155	8	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS6 CLDN10 RBM20 ZNF354C SLIT2 EGF MEGF6 LPL	3.01e-07	186	155	8	8eafd4bea692f7ef33de27dd53f9d1fe67deaad8
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	VWF LAMA3 LAMA4 LAMC1 TNS2 DGKH DIPK2B KDR	3.01e-07	186	155	8	a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	CACNA1D LAMA2 LAMA4 SLIT2 FBN1 PCDH15 LTBP2 C7	3.13e-07	187	155	8	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	STAB2 VWF LAMA4 PKHD1L1 DIPK2B FBN1 MEGF6 KDR	3.26e-07	188	155	8	26915db8863f4115b46a81982e187322e21600fd
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	STAB2 VWF LAMA4 PKHD1L1 DIPK2B FBN1 MEGF6 KDR	3.26e-07	188	155	8	3f76c0f912f8f023ea425be7f43593b3d7f967e3
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	STAB2 VWF LAMA4 PKHD1L1 DIPK2B FBN1 MEGF6 KDR	3.26e-07	188	155	8	61ee7b152745164293d8a44ef91ee2393efbdca5
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	CACNA1D LAMA2 LAMA4 SLIT2 FBN1 PCDH15 LTBP2 C7	3.53e-07	190	155	8	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	Endothelial-A-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	VWF DIPK2B POSTN FBN1 PXDN CLU KDR C7	3.68e-07	191	155	8	f702dfe88a9b04091dae87df61b2b4f43525f86a
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VLDLR LAMA2 LAMA4 LAMC1 FBN1 ADAMTS15 TWSG1 C7	3.68e-07	191	155	8	997abf0cc5873bed0372c4a333ed307fa72774d2
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CACNA1D LAMA2 LAMA4 SLIT2 SMPDL3A SLIT1 PCDH15 C7	3.98e-07	193	155	8	9f69edc97b868d23998abc98928a2e89a885ef8a
ToppCell	facs-MAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS6 LAMA2 LAMA4 LAMC1 FBN1 LPL TWSG1 C7	3.98e-07	193	155	8	f95b95c58a6edb8a03dd15ae166f47f9f33d8bd6
ToppCell	facs-Lung-nan-3m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS6 LAMA2 LAMA4 LAMC1 FBN1 ADAMTS15 TWSG1 C7	3.98e-07	193	155	8	d9c20a092b507c43fcf7ccb04073fecd27d1749c
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1D LAMA2 LAMA4 LAMC1 SLIT2 FBN1 PCDH15 ADAMTS15	3.98e-07	193	155	8	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D231\|Adult / Lineage, Cell type, age group and donor	CACNA1D LAMA2 LAMA4 SLIT2 FBN1 PCDH15 LTBP2 C7	3.98e-07	193	155	8	ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCell	facs-MAT-Fat-3m-Mesenchymal-mesenchymal_progenitor\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS6 LAMA2 LAMA4 LAMC1 FBN1 LPL TWSG1 C7	3.98e-07	193	155	8	85faf6c5ce4769615a4eca036e2ba307e176bb52
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	CACNA1D LAMA2 LAMA4 LAMC1 SLIT2 FBN1 PCDH15 C7	3.98e-07	193	155	8	acad568621ed677031797b8c2e34dafea798d681
ToppCell	facs-MAT-Fat-3m-Mesenchymal\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS6 LAMA2 LAMA4 LAMC1 FBN1 LPL TWSG1 C7	3.98e-07	193	155	8	110a7d2ba7d066c2be38be98b643b76c520dd980
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1D LAMA2 LAMA4 LAMC1 SLIT2 FBN1 PCDH15 ADAMTS15	4.14e-07	194	155	8	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA1D LAMA2 LAMA4 SLIT2 FBN1 LPL PCDH15 C7	4.14e-07	194	155	8	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CACNA1D LAMA2 LAMA4 SLIT2 SMPDL3A SLIT1 PCDH15 C7	4.14e-07	194	155	8	71d3c7448b1734de54187f902f65649f9283bd4c
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA2 LAMC1 TNS2 NCBP1 POSTN FBN1 PXDN LTBP2	4.30e-07	195	155	8	78cfde21dde4b877fc76c8b0d5ddaabe44b912d7
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	CACNA1D LAMA2 LAMA4 LAMC1 SLIT2 FBN1 PCDH15 C7	4.30e-07	195	155	8	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	IPF-Stromal-Myofibroblast\|IPF / Disease state, Lineage and Cell class	LAMA2 LAMA4 LAMC1 POSTN SLIT2 FBN1 LTBP2 C7	4.47e-07	196	155	8	2d0a48e49b3b37bb66e33e74c52915911e1f8a74
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA2 LAMA4 LAMC1 SLIT2 FBN1 PCDH15 LTBP2 C7	4.47e-07	196	155	8	42e9828222a9663525d571633e8a454c30bfa7f8
ToppCell	distal-Endothelial-Lymphatic-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	STAB2 PDGFA LAMA4 PKHD1L1 DIPK2B CLU ATRNL1 ADAMTS15	4.47e-07	196	155	8	b0f23dc802a2c2a56a08d398a464ea78b58ade4c
ToppCell	LPS_IL1RA_TNF\|World / Treatment groups by lineage, cell group, cell type	LAMA3 LAMA4 LAMC1 SLIT2 CLU LPL ADAMTS15 C7	4.65e-07	197	155	8	0a6550dce156fc81f15b1e7830d331ca50d87d06
ToppCell	COPD-Stromal\|COPD / Disease state, Lineage and Cell class	LAMA2 LAMA4 LAMC1 SLIT2 FBN1 CLU LTBP2 C7	4.65e-07	197	155	8	d5390d86acaa8c39f1da893e8d2271f9ed2951d7
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	LAMA2 LAMA4 LAMC1 POSTN SLIT2 FBN1 LTBP2 C7	4.65e-07	197	155	8	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1D LAMA2 LAMA4 LAMC1 SLIT2 FBN1 LTBP2 C7	4.83e-07	198	155	8	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VLDLR WNT4 POSTN SLIT2 FBN1 PXDN MEGF6 C7	4.83e-07	198	155	8	9541d68a1a6247dbd7161a62644eea6527c2c8ff
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|367C / Donor, Lineage, Cell class and subclass (all cells)	CACNA1D LAMA2 LAMA4 SLIT2 FBN1 SMPDL3A LTBP2 C7	4.83e-07	198	155	8	a9afedbc0556faf4a46f7bf28f4a9adb3bc859d8
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	CACNA1D LAMA2 LAMA4 LAMC1 SLIT2 FBN1 LTBP2 C7	4.83e-07	198	155	8	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	Control-Stromal\|Control / Disease state, Lineage and Cell class	LAMA2 LAMA4 SLIT2 FBN1 PXDN CLU LTBP2 C7	4.83e-07	198	155	8	ae726b6b7f0a4107899be4d32ac256ffa0bd8d59
ToppCell	5'-Adult-LymphNode-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWF TNS2 PKHD1L1 DIPK2B CLU LPL PCDH15 C7	4.83e-07	198	155	8	d7e15e61b6018e4c36461c9471ee29601929925c
ToppCell	ASK428-Endothelial\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	STAB2 VWF LAMA4 PKHD1L1 DIPK2B POSTN CLU KDR	4.83e-07	198	155	8	d69d0ff115298596173a4278897a65007a71f5df
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	CACNA1D LAMA2 LAMA4 LAMC1 SLIT2 FBN1 LTBP2 C7	4.83e-07	198	155	8	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	5'-Adult-Appendix-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	STAB2 VWF LAMA4 TNS2 PKHD1L1 DIPK2B CLU KDR	4.83e-07	198	155	8	90e85fe7a0ab376a41666dfff6c0e95b7f1c9475
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	CACNA1D LAMA2 LAMA4 SLIT2 FBN1 SMPDL3A LTBP2 C7	4.83e-07	198	155	8	7b5350768f306ec528e271d2ac4470bf668ec6f0
ToppCell	metastatic_Brain-Fibroblasts-FB-like_cells\|metastatic_Brain / Location, Cell class and cell subclass	LAMA2 LAMA4 WNT4 ADAM22 POSTN FBN1 LTBP2 C7	5.02e-07	199	155	8	12133087eae9f0e9b6c13a71e8187117768e64ce
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LAMA2 LAMA4 LAMC1 SLIT2 FBN1 LTBP2 C7 RSPO1	5.02e-07	199	155	8	e1f1950d6f840485e263b83dc81b98910be3ae7a
ToppCell	PCW_10-12-Mesenchymal\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CACNA1D LAMA2 LAMA4 POSTN SLIT2 FBN1 LPL C7	5.02e-07	199	155	8	a09292de4c4447b8eee55d401808e43b817321cc
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CACNA1D LAMA4 LAMC1 SLIT2 FBN1 LPL ADAMTS15 C7	5.02e-07	199	155	8	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CACNA1D LAMA4 LAMC1 SLIT2 FBN1 LPL ADAMTS15 C7	5.21e-07	200	155	8	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	cellseq-Mesenchymal-Fibroblastic\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1D LAMA2 LAMA4 LAMC1 SLIT2 FBN1 LTBP2 C7	5.21e-07	200	155	8	8978867bf69c830b1e48cac2ad6b512dbe60f149
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1D LAMA2 LAMA4 SLIT2 FBN1 PCDH15 LTBP2 C7	5.21e-07	200	155	8	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1D LAMA2 LAMA4 SLIT2 FBN1 PCDH15 LTBP2 C7	5.21e-07	200	155	8	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1D LAMA2 LAMA4 SLIT2 FBN1 PCDH15 LTBP2 C7	5.21e-07	200	155	8	34f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1D LAMA2 LAMA4 SLIT2 FBN1 ATRNL1 LTBP2 RSPO1	5.21e-07	200	155	8	fb53be20392a8309a7393774c774a1b1aec6e676
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	CACNA1D LAMA4 LAMC1 SLIT2 FBN1 PCDH15 ADAMTS15 C7	5.21e-07	200	155	8	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1D LAMA2 LAMA4 SLIT2 FBN1 ATRNL1 LTBP2 RSPO1	5.21e-07	200	155	8	58b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	EPHA6 RPH3A EYS ATRNL1 PCDH15 USH2A RNF212B	8.95e-07	148	155	7	d6ac5972267254651dfbe16bb4e9a62228093cc7
ToppCell	droplet-Liver-HEPATOCYTES-1m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1D LRP8 POSTN ADGRE4P ZMYM1 C6 RSPO1	1.17e-06	154	155	7	66c93733116e31b65dfb4b0b00de5c39d19cdb84
ToppCell	Adult-Mesenchymal-chondrocyte\|Adult / Lineage, Cell type, age group and donor	LAMA2 LAMA4 TNS2 SLIT2 FBN1 LTBP2 C7	1.45e-06	159	155	7	3f7305ee76447064b5c846c4f576360a2f7e0b7c
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHA6 ADAM7 PKHD1L1 OTOGL PCDH15 ROS1 USH2A	1.64e-06	162	155	7	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	343B-Myeloid-Macrophage-FABP4+_Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	LIN54 VWCE SLIT2 LPL ROS1 ZNF107 ZNF286A	1.93e-06	166	155	7	f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2
ToppCell	-Donor_05\|World / lung cells shred on cell class, cell subclass, sample id	LAMA2 LAMA4 TNFRSF17 FBN1 SLIT1 LTBP2 C7	2.17e-06	169	155	7	8ebe9a88111c53a09c25a7b6a164a0a17880458d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA2 LAMA4 LHX8 SLIT2 FBN1 LTBP2 C7	2.74e-06	175	155	7	795a6564d5a75ffd35d39f5274b9e8d28708bbc8
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	LAMA2 LAMA4 SLIT2 FBN1 LTBP2 C7 RSPO1	2.84e-06	176	155	7	510f9a14dc1c151d24d079e0cc004cdf4f86336c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STAB2 TMPRSS6 LAMA4 PKHD1L1 DIPK2B FBN1 KDR	2.95e-06	177	155	7	c274fbdc141855ff4581d437d4997c64cc193278
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STAB2 TMPRSS6 LAMA4 PKHD1L1 DIPK2B FBN1 KDR	2.95e-06	177	155	7	f5e6df5cafd003bbfbb3b634ee58d0b1e2be5cc7
ToppCell	(1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)\|(1)_Control_(PBS) / Stress and Cell class	VLDLR PDGFA TMPRSS6 POSTN SLIT2 CLU ZMYM1	2.95e-06	177	155	7	d9e5ac5b8949a77e88e8094079167e4cf2c1bbd1
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STAB2 TMPRSS6 LAMA4 PKHD1L1 DIPK2B FBN1 KDR	2.95e-06	177	155	7	c8a51e480b978dc0ded85583261f2c892e085be8
ToppCell	facs-Lung-nan-3m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFA TRPC1 LAMA2 WNT4 POSTN RAD51AP2 LTBP2	3.18e-06	179	155	7	7078022e60faa86444f2a2c6eb9f767cc66b5cfa
ToppCell	facs-Lung-nan-3m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFA TRPC1 LAMA2 WNT4 POSTN RAD51AP2 LTBP2	3.18e-06	179	155	7	d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF LAMC1 POSTN IFIH1 PXDN LPL KDR	3.30e-06	180	155	7	455d1e3ccf2ab609954f3b870e8f514ddca735f4
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STAB2 LAMA4 PKHD1L1 DIPK2B FBN1 ADAMTS15 KDR	3.55e-06	182	155	7	41b070085edba7a58b81c20aa4942d06f745acf8
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STAB2 LAMA4 PKHD1L1 DIPK2B FBN1 ADAMTS15 KDR	3.55e-06	182	155	7	5e9a67b2de0daa4fdc344b10a857d8a901ad810e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STAB2 LAMA4 PKHD1L1 DIPK2B FBN1 ADAMTS15 KDR	3.55e-06	182	155	7	b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LAMA2 DGKD DGKH POSTN SLIT2 ATRNL1 LPL	3.68e-06	183	155	7	8a799807fbf24456a9811e0c64068187940a2f71
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NSD2 DTL MCM3 LRP8 AFP LPL NEIL3	3.68e-06	183	155	7	42dc31d587fbb9724b2f0be5ee8ed77233f67b86
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB2 COL19A1 PKHD1L1 OTOGL PCDH15 ROS1 USH2A	3.81e-06	184	155	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB2 COL19A1 PKHD1L1 OTOGL PCDH15 ROS1 USH2A	3.81e-06	184	155	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB2 COL19A1 PKHD1L1 OTOGL PCDH15 ROS1 USH2A	3.81e-06	184	155	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LAMA2 LAMC1 SLIT2 FBN1 PXDN LTBP2 C7	3.95e-06	185	155	7	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
Computational	Genes in the cancer module 58.	CLU C5 C6 C7	2.06e-05	21	86	4	MODULE_58
Computational	Complement.	CLU C5 C6 C7	3.01e-05	23	86	4	MODULE_130
Computational	Neighborhood of PTPRB	ZNF266 COL19A1 JADE3 ZSCAN26 SPATA2 FAS ADAM22 ZNF33B ZBTB40 KDR	3.32e-05	254	86	10	MORF_PTPRB
Computational	Neighborhood of SUPT3H	ZNF266 COL19A1 JADE3 ZSCAN26 SPATA2 FAS ADAM22 ZNF33B ZBTB40 KDR C6	5.72e-05	328	86	11	MORF_SUPT3H
Computational	Neighborhood of FSHR	ZNF266 COL19A1 JADE3 ZSCAN26 FAS ADAM22 ZNF33B ZBTB40 KDR C6	7.34e-05	279	86	10	MORF_FSHR
Computational	Adhesion molecules.	VWF LAMA2 LAMA3 LAMA4 CLDN10 POSTN FBN1	1.30e-04	141	86	7	MODULE_122
Computational	Neighborhood of MYL3	COL19A1 ZSCAN26 ZNF33B ZBTB40 KDR	2.35e-04	70	86	5	MORF_MYL3
Computational	Neighborhood of ATF2	ZNF266 COL19A1 JADE3 ZSCAN26 SPATA2 FAS ADAM22 ZNF33B ZBTB40 C6	2.90e-04	330	86	10	MORF_ATF2
Computational	Neighborhood of TNFRSF6	ZNF266 COL19A1 ZSCAN26 SPATA2 FAS ZBTB40 KDR	3.69e-04	167	86	7	MORF_TNFRSF6
Computational	Neighborhood of CAMK4	ZNF266 COL19A1 JADE3 ZSCAN26 SPATA2 FAS ZNF33B ZBTB40 KDR	4.99e-04	290	86	9	MORF_CAMK4
Computational	Neighborhood of IL16	ZNF266 COL19A1 JADE3 SPATA2 FAS ZNF33B ZBTB40 KDR	6.33e-04	239	86	8	MORF_IL16
Computational	Genes upregulated in subsets of cells of a given type within various tumors	VWF POSTN CLU C7	6.65e-04	50	86	4	GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_HEV_1
Computational	Neighborhood of TTN	ZNF266 JADE3 ZSCAN26 ZBTB40	6.65e-04	50	86	4	MORF_TTN
Computational	Neighborhood of MLLT10	ZNF266 COL19A1 JADE3 ZSCAN26 SPATA2 FAS ZNF33B ZBTB40 KDR	6.68e-04	302	86	9	MORF_MLLT10
Computational	Neighborhood of KDR	ZNF266 COL19A1 ZSCAN26 FAS KDR	9.16e-04	94	86	5	MORF_KDR
Computational	Neighborhood of CDH11	LAMC1 FBN1 PXDN	1.00e-03	25	86	3	GNF2_CDH11
Computational	Neighborhood of RAD51L3	ZNF266 COL19A1 JADE3 ZSCAN26 SPATA2 FAS ADAM22 ZNF33B ZBTB40 KDR	1.00e-03	387	86	10	MORF_RAD51L3
Computational	Neighborhood of ERCC4	ZNF266 COL19A1 JADE3 ZSCAN26 SPATA2 FAS ZNF33B ZBTB40 KDR	1.03e-03	321	86	9	MORF_ERCC4
Computational	Neighborhood of MAGEA9	ZNF266 COL19A1 JADE3 ZSCAN26 SPATA2 FAS ZNF33B ZBTB40 KDR C6	1.96e-03	423	86	10	MORF_MAGEA9
Computational	Neighborhood of MMP1	FBN1 PXDN TWSG1	2.07e-03	32	86	3	GNF2_MMP1
Drug	AC1L1G72	LAMA2 LAMA3 LAMA4 LAMC1	6.24e-07	11	153	4	CID000003553
Drug	Calcort	LAMA2 LAMA3 LAMA4 LAMC1 PLAUR	5.39e-06	38	153	5	CID000026709
Drug	vinylene	ZNF266 ZNF569 ZSCAN26 NSD1 ZNF300 ZNF461 ZNF33A ZNF107 ZNF418 PRDM15	6.48e-06	245	153	10	CID000006326
Disease	Marfan Syndrome	LAMC1 FBN1 LTBP2	1.98e-05	11	148	3	C0024796
Disease	factor VIII measurement, coronary artery disease	STAB2 VWF ZSCAN26 RPH3A FURIN LPL	2.34e-05	113	148	6	EFO_0001645, EFO_0004630
Disease	von Willebrand factor measurement, coronary artery disease	STAB2 VWF ZSCAN26 RPH3A FURIN LPL	2.99e-05	118	148	6	EFO_0001645, EFO_0004629
Disease	hepcidin:transferrin saturation ratio	TMPRSS6 SLITRK1 ZNF551	5.38e-05	15	148	3	EFO_0007902
Disease	gestational age	TCEA2 WNT4 SLIT2 EYS ZNF846 TET3	7.17e-05	138	148	6	EFO_0005112
Disease	Sotos syndrome 1 (implicated_via_orthology)	NSD2 NSD1	7.47e-05	3	148	2	DOID:0112103 (implicated_via_orthology)
Disease	Weill-Marchesani syndrome	FBN1 LTBP2	7.47e-05	3	148	2	C0265313
Disease	prostate adenocarcinoma (biomarker_via_orthology)	CLU KDR	7.47e-05	3	148	2	DOID:2526 (biomarker_via_orthology)
Disease	Weill-Marchesani Syndrome, Autosomal Dominant	FBN1 LTBP2	7.47e-05	3	148	2	C1869115
Disease	Weill-Marchesani Syndrome, Autosomal Recessive	FBN1 LTBP2	7.47e-05	3	148	2	C1869114
Disease	acute kidney failure (is_marker_for)	FAS EGF TNFRSF1A	7.99e-05	17	148	3	DOID:3021 (is_marker_for)
Disease	cerebrospinal fluid biomarker measurement	POSTN MANSC1 SMPDL3A MICB C7	1.26e-04	96	148	5	EFO_0006794
Disease	Weill-Marchesani syndrome	FBN1 LTBP2	1.49e-04	4	148	2	cv:C0265313
Disease	periostin measurement	STAB2 POSTN	1.49e-04	4	148	2	EFO_0020628
Disease	Weill-Marchesani syndrome (is_implicated_in)	FBN1 LTBP2	1.49e-04	4	148	2	DOID:0050475 (is_implicated_in)
Disease	lung non-small cell carcinoma (is_marker_for)	NSD2 KAT2A ADAM28 EGF KDR TNFRSF1A	2.18e-04	169	148	6	DOID:3908 (is_marker_for)
Disease	Usher Syndrome, Type II	PCDH15 USH2A	2.47e-04	5	148	2	C1568249
Disease	Prostatic Neoplasms	DCAF6 STAB2 PSCA LAMC1 WNT4 ADAM28 EGF CLU LPL PLAUR ZMYM3	2.91e-04	616	148	11	C0033578
Disease	Malignant neoplasm of prostate	DCAF6 STAB2 PSCA LAMC1 WNT4 ADAM28 EGF CLU LPL PLAUR ZMYM3	2.91e-04	616	148	11	C0376358
Disease	urate measurement, bone density	ZNF695 TMPRSS6 PDYN LIN54 DGKD EYS MANSC1 TPH2 ADGRE4P USH2A CRBN	3.04e-04	619	148	11	EFO_0003923, EFO_0004531
Disease	blood nickel measurement	CLDN10 SLIT2 EYS ZNF33B USH2A	3.56e-04	120	148	5	EFO_0007583
Disease	Pathologic Neovascularization	CLU KDR	3.70e-04	6	148	2	C0027686
Disease	CD97 antigen measurement	C6 C7	3.70e-04	6	148	2	EFO_0020250
Disease	carbonic anhydrase 4 measurement	C6 C7	3.70e-04	6	148	2	EFO_0020230
Disease	muscular disease (is_implicated_in)	CLU LPL	3.70e-04	6	148	2	DOID:0080000 (is_implicated_in)
Disease	Stage IV Skin Melanoma	ADAM7 ADAM28	5.16e-04	7	148	2	C1321872
Disease	calcineurin subunit B type 1 measurement	C6 C7	5.16e-04	7	148	2	EFO_0020215
Disease	prostatic hypertrophy (biomarker_via_orthology)	CLU KDR	5.16e-04	7	148	2	DOID:11132 (biomarker_via_orthology)
Disease	Liver Cirrhosis, Experimental	ATRN VWF PDGFA SNAP23 FAS FBN1 PXDN EGF AFP SNX7 LPL C7	5.51e-04	774	148	12	C0023893
Disease	Complement deficiency disease	C5 C6 C7	6.04e-04	33	148	3	C0272242
Disease	mesangial proliferative glomerulonephritis (biomarker_via_orthology)	VWF FBN1	6.86e-04	8	148	2	DOID:4783 (biomarker_via_orthology)
Disease	lung non-small cell carcinoma (is_implicated_in)	NSD2 ADAM28 EGF KDR TNFRSF1A	6.96e-04	139	148	5	DOID:3908 (is_implicated_in)
Disease	ulcerative colitis (biomarker_via_orthology)	FAS MUC2	8.79e-04	9	148	2	DOID:8577 (biomarker_via_orthology)
Disease	Marfan Syndrome, Type I	LAMC1 FBN1	8.79e-04	9	148	2	C4721845
Disease	apolipoprotein D measurement	C6 C7	8.79e-04	9	148	2	EFO_0020156
Disease	Pulmonary Cystic Fibrosis	SCNN1G TNFRSF1A	8.79e-04	9	148	2	C0392164
Disease	Fibrocystic Disease of Pancreas	SCNN1G TNFRSF1A	8.79e-04	9	148	2	C1527396
Disease	kallikrein-14 measurement	C6 C7	8.79e-04	9	148	2	EFO_0020513
Disease	Malignant neoplasm of breast	VWF COL19A1 PDGFA ZNF569 ZSWIM5 NSD2 TMPRSS6 LRRC37A2 LAMA2 LRRC37A EGF OTOGL AFP KDR	1.05e-03	1074	148	14	C0006142
Disease	tropomyosin beta chain measurement	C6 C7	1.10e-03	10	148	2	EFO_0020787
Disease	prostate adenocarcinoma (is_marker_for)	PDGFA KDR	1.10e-03	10	148	2	DOID:2526 (is_marker_for)
Disease	beta-nerve growth factor measurement	DGKH FAS RPH3A	1.23e-03	42	148	3	EFO_0008035
Disease	myocardial infarction (biomarker_via_orthology)	VWF POSTN PLAUR C7 TNFRSF1A	1.31e-03	160	148	5	DOID:5844 (biomarker_via_orthology)
Disease	polymyositis (is_marker_for)	SLIT2 TNFRSF1A	1.33e-03	11	148	2	DOID:0080745 (is_marker_for)
Disease	tumor necrosis factor receptor superfamily member 11B measurement	C6 C7	1.33e-03	11	148	2	EFO_0020801
Disease	Barrett's esophagus (is_marker_for)	FAS MUC2	1.33e-03	11	148	2	DOID:9206 (is_marker_for)
Disease	Cystic Fibrosis	SCNN1G TNFRSF1A	1.33e-03	11	148	2	C0010674
Disease	serum IgG glycosylation measurement	STAB2 COL19A1 WNT4 EYS PXDN EGF SLIT1 USH2A CRBN	1.34e-03	523	148	9	EFO_0005193
Disease	psoriasis (is_marker_for)	CLU KDR TNFRSF1A	1.41e-03	44	148	3	DOID:8893 (is_marker_for)
Disease	myocardial infarction (is_implicated_in)	LRP8 CLU LPL KDR	1.58e-03	99	148	4	DOID:5844 (is_implicated_in)
Disease	complement component C7 measurement	C6 C7	1.60e-03	12	148	2	EFO_0008093
Disease	dementia (is_implicated_in)	VLDLR LRP8	1.60e-03	12	148	2	DOID:1307 (is_implicated_in)
Disease	focal segmental glomerulosclerosis (biomarker_via_orthology)	VLDLR LPL	1.60e-03	12	148	2	DOID:1312 (biomarker_via_orthology)
Disease	tyrosine-protein kinase ZAP-70 measurement	C6 C7	1.60e-03	12	148	2	EFO_0020833
Disease	macular retinal edema (is_marker_for)	CLU KDR	1.60e-03	12	148	2	DOID:4449 (is_marker_for)
Disease	ovarian serous carcinoma	LAMA3 LAMA4 RSPO1	1.60e-03	46	148	3	EFO_1001516
Disease	end stage renal disease (is_marker_for)	VWF PLAUR TNFRSF1A	1.60e-03	46	148	3	DOID:783 (is_marker_for)
Disease	JT interval	CACNA1D LIN54 DTL DGKD PXDN LTBP2	1.62e-03	248	148	6	EFO_0007885
Disease	blood cobalt measurement	PRDM5 SLIT2 EYS USH2A	1.70e-03	101	148	4	EFO_0007577
Disease	systemic lupus erythematosus (is_marker_for)	FAS CLU TNFRSF1A	1.71e-03	47	148	3	DOID:9074 (is_marker_for)
Disease	xanthine measurement	ADAM22 EYS	1.88e-03	13	148	2	EFO_0010548
Disease	complement component C6 measurement	C6 C7	1.88e-03	13	148	2	EFO_0020281
Disease	tyrosine-protein phosphatase non-receptor type 1 measurement	PDYN C7	1.88e-03	13	148	2	EFO_0020834
Disease	Unipolar Depression	PDYN DGKH LRP8 EGF TPH2 KDR	2.01e-03	259	148	6	C0041696
Disease	amino acid measurement	VWF ADAM28 RAD51AP2 SLIT2 PXDN CLU SLIT1 ZBTB40 C5 MUC2	2.29e-03	678	148	10	EFO_0005134
Disease	coronary artery disease, factor VII measurement	ZSCAN26 RPH3A FURIN LPL	2.40e-03	111	148	4	EFO_0001645, EFO_0004619
Disease	systemic scleroderma (is_marker_for)	VWF CLU KDR	2.41e-03	53	148	3	DOID:418 (is_marker_for)
Disease	factor XI measurement, coronary artery disease	ZSCAN26 RPH3A FURIN LPL	2.73e-03	115	148	4	EFO_0001645, EFO_0004694
Disease	preeclampsia, hypertension, pregnancy-induced	TNS2 FURIN	2.86e-03	16	148	2	EFO_0000668, MONDO_0024664
Disease	rheumatoid arthritis (is_implicated_in)	FAS PLAUR TNFRSF1A	3.12e-03	58	148	3	DOID:7148 (is_implicated_in)
Disease	phosphoglyceric acid measurement	ZNF107 ZNF679	3.23e-03	17	148	2	EFO_0010523
Disease	lupus nephritis (is_marker_for)	EGF TNFRSF1A	3.23e-03	17	148	2	DOID:0080162 (is_marker_for)
Disease	dermatomyositis (is_marker_for)	FAS SLIT2	3.23e-03	17	148	2	DOID:10223 (is_marker_for)
Disease	ischemia (implicated_via_orthology)	SCNN1G TNFRSF1A	3.23e-03	17	148	2	DOID:326 (implicated_via_orthology)
Disease	IGF-1 measurement	TCEA2 STAB2 EPHA6 LIN54 DGKH ZNF12 INSL6 SLIT1	3.32e-03	488	148	8	EFO_0004627
Disease	syndrome (implicated_via_orthology)	NSD2 NSD1	3.63e-03	18	148	2	DOID:225 (implicated_via_orthology)
Disease	serum hepcidin measurement	TMPRSS6 DGKH	3.63e-03	18	148	2	EFO_0004504
Disease	Acute Myeloid Leukemia, M1	TCEA2 NSD1 FAS PXDN	3.68e-03	125	148	4	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	TCEA2 NSD1 FAS PXDN	3.68e-03	125	148	4	C1879321
Disease	coronary artery disease, plasminogen activator inhibitor 1 measurement	RPH3A FURIN LPL	3.94e-03	63	148	3	EFO_0001645, EFO_0004792
Disease	urolithiasis	DGKD DGKH CLDN10	3.94e-03	63	148	3	MONDO_0024647
Disease	renal cell carcinoma (is_marker_for)	VWF FAS AFP TNFRSF1A	4.01e-03	128	148	4	DOID:4450 (is_marker_for)
Disease	Hypertriglyceridemia	LAMC1 LPL	4.04e-03	19	148	2	EFO_0004211
Disease	bipolar disorder (is_marker_for)	VWF TPH2	4.04e-03	19	148	2	DOID:3312 (is_marker_for)
Disease	renovascular hypertension (biomarker_via_orthology)	PDGFA LAMA2	4.04e-03	19	148	2	DOID:1591 (biomarker_via_orthology)
Disease	factor VIII measurement, Ischemic stroke	STAB2 VWF	4.04e-03	19	148	2	EFO_0004630, HP_0002140
Disease	Cardiomyopathies	LAMA4 FAS RBM20 LPL	4.23e-03	130	148	4	C0878544
Disease	Alzheimer's disease (is_implicated_in)	VLDLR FAS LRP8 LPL	4.47e-03	132	148	4	DOID:10652 (is_implicated_in)
Disease	Deaf Mutism	CACNA1D PCDH15	4.47e-03	20	148	2	C4082305
Disease	Deafness, Acquired	CACNA1D PCDH15	4.47e-03	20	148	2	C0751068
Disease	Hearing Loss, Extreme	CACNA1D PCDH15	4.47e-03	20	148	2	C0086395
Disease	Complete Hearing Loss	CACNA1D PCDH15	4.47e-03	20	148	2	C0581883
Disease	Bilateral Deafness	CACNA1D PCDH15	4.47e-03	20	148	2	C3665473
Disease	cortisol measurement	DGKH EGFEM1P	4.47e-03	20	148	2	EFO_0005843
Disease	Prelingual Deafness	CACNA1D PCDH15	4.47e-03	20	148	2	C0011052
Disease	breast carcinoma (is_marker_for)	FAS ADAM28 KDR	4.49e-03	66	148	3	DOID:3459 (is_marker_for)
Disease	ovarian cancer (is_marker_for)	FAS EGF TNFRSF1A	4.88e-03	68	148	3	DOID:2394 (is_marker_for)
Disease	bone density, lean body mass	WNT4 ZBTB40	4.93e-03	21	148	2	EFO_0003923, EFO_0004995
Disease	hepatitis B (is_marker_for)	FAS PLAUR	4.93e-03	21	148	2	DOID:2043 (is_marker_for)
Disease	type 2 diabetes mellitus (is_marker_for)	CACNA1D LPL KDR PLAUR	4.97e-03	136	148	4	DOID:9352 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
CNKALCASDVSKCLI	TWSG1	26	Q9GZX9
CNECGKSFKCSSSLI	ZNF286A	496	Q9HBT8
TCEECGKAFGCKSNL	ZNF354C	441	Q86Y25
IKATFQCALGECCEK	ADAM28	441	Q9UKQ2
TCAEGECCESCQIKK	ADAM7	441	Q9H2U9
ECCESCQIKKAGSIC	ADAM7	446	Q9H2U9
KCEDINECETGLAKC	ADGRE4P	51	Q86SQ3
CVLEGAECCKKCTLT	ADAM22	466	Q9P0K1
NKCTSLCCKQCQETE	CRBN	316	Q96SW2
LCCKQCQETEITTKN	CRBN	321	Q96SW2
CKNCTCGLAEELEKE	CIAPIN1	246	Q6FI81
ALCSCAQVGTNKELC	CCL18	16	P55774
KITGKCLSVCSEENA	SLC22A18AS	166	Q8N1D0
SCTKEDCKDDILINC	DCAF6	176	Q58WW2
ESVKQKCVKSCNCVT	DTL	561	Q9NZJ0
KCVKSCNCVTELDGQ	DTL	566	Q9NZJ0
KACVTDSTGVSNCKD	CLDN10	51	P78369
GLDKCNACIGTSICK	DIPK2B	56	Q9H7Y0
IVETLGCCSVLCSDK	ATP2C2	366	O75185
TSVCVQGKCIKAGCD	ADAMTS15	646	Q8TE58
FCKKCVTLEKCAVCG	RNF212B	26	A8MTL3
VTLEKCAVCGTACKH	RNF212B	31	A8MTL3
LGCSHTVCKTCLNKL	RC3H2	31	Q9HBD1
TDSCVEKSVSGKQIC	RAD51AP2	86	Q09MP3
CSLKNASTAKKCVSC	RANBP2	1361	P49792
CSVCLVRNEASATKC	RANBP2	1671	P49792
DQKDKICPETCLCVT	RBM20	936	Q5T481
CSCKQAEGCVREITK	PDS5B	571	Q9NTI5
INEECSLKCCSSDTK	NSD1	806	Q96L73
LGVFSACKANETCKC	KAT2A	106	Q92830
ICSVCNKKCSSASSL	PRDM5	296	Q9NQX1
EAVCKTVKLHCNSAC	LRRC37A3	1036	O60309
SSICKCIGCKNFEES	LIN54	621	Q6MZP7
TKEICANGCSCLSEE	EYS	531	Q5T1H1
SCDADGTSTQCKIKI	EYS	1066	Q5T1H1
TGACLCKENVEGTEC	LAMA3	1421	Q16787
EAVCKTVKLHCNSAC	LRRC37A2	1036	A6NM11
EAVCKTVKLHCNSAC	LRRC37A	1036	A6NMS7
CKVGEKSACSLESNL	NCBP1	36	Q09161
CTLINKPSSKACDAC	NEIL3	326	Q8TAT5
SSVTCDKTCKAFQIC	SMPDL3A	416	Q92484
ICEKCENLTTGKHCE	ATRN	1076	O75882
FCTTKGVKGDECQLC	ATRN	1126	O75882
KVLICESQVTCCCLS	DYNC2I1	691	Q8WVS4
LELRNGCLCCSVKDS	CBWD1	101	Q9BRT8
CSSKEAFEKGLCLSC	LPL	291	P06858
SGAKIKVDCNTCTCK	MUC2	831	Q02817
NITVCKCNTSLCKEK	MUC2	4881	Q02817
SSKCQDCVCTDKVDN	MUC2	4941	Q02817
DCLSRCSLCAVKTQD	PDYN	21	P01213
DSCSEVKCCLPFSEK	DDIAS	966	Q8IXT1
LVVLNCKSICSLGCD	IFNA5	11	P01569
SCFVCKESKTDVKRC	NSD2	716	O96028
SCCSTKNISGDKACN	MANSC1	66	Q9H8J5
GKCVCNSCGLEIVDK	LHX8	71	Q68G74
EAVCKTVKLHCNTAC	LRRC37B	726	Q96QE4
ETKKCSCSDQTGQCT	LAMA2	1121	P24043
NCDITSDGCCDLTKL	NLRP2	906	Q9NX02
LCVPCCKKKTSAAEG	MICB	326	Q29980
PVSAKCAVCDKTCGS	DGKH	256	Q86XP1
NEEECAVKKSCQLCT	PTTG1IP2	46	P0DTF9
LSCVVCVEGIVTKCS	MCM3	121	P25205
LSTECVCITGVKCTT	PCDH15	1836	Q96QU1
LDDTIGICNEGKKCC	DEFB130B	46	P0DP73
EKCSASTSKCVCLLP	C6	871	P13671
CISEGEDATCQCLKG	EGF	846	P01133
LIAQETCCEISDTKC	COL19A1	236	Q14993
NEIGVGVSKASCCCS	FBN1	1551	P35555
KCIETVPQDSCKTCF	FNIP1	886	Q8TF40
GCKTLTSSQACVVCE	FURIN	586	P09958
IQKVCEGAACKCVEA	C5	1516	P01031
KCDAESSKCVCREAS	C7	781	P10643
CLSGKLCCANDEEEK	DEFB128	46	Q7Z7B8
LCKNCSVLACSGEDI	IFIH1	906	Q9BYX4
CFCTTKGIKGDQCQL	ATRNL1	1076	Q5VV63
CLTLGLCKDAECVNT	LTBP2	626	Q14767
SAKCTVCDKTCGSVL	DGKD	246	Q16760
GESCSLCSKEEKCVK	GLIPR1L1	186	Q6UWM5
CAVVPKTKEVVCTNC	LAMC1	781	P11047
LDDTIGICNEGKKCC	DEFB130A	46	P0DP74
TFCKGAELKSICCII	GTF2IRD2	641	Q86UP8
TFCKGAELKSICCII	GTF2IRD2B	641	Q6EKJ0
TLECSAKNGSCTCKS	EGFEM1P	76	Q0D2K5
GKKNITCCDTDLCNA	PSCA	71	O43653
ICRNTVGSFECSCKK	SCUBE3	291	Q8IX30
ELGCQSVCKEACSFK	SCNN1G	446	P51170
DLCSKTTCKNDGVCT	MEP1B	606	Q16820
RGCCGSLCQAISKSK	CACNA1D	486	Q01668
KLKTGACIQCSIKSC	JADE3	316	Q92613
SCCKAENAVECFQTK	AFP	191	P02771
TCTKQVCPAEKLSCG	LRP8	121	Q14114
SKIEQECTECVCVGG	OTOGL	456	Q3ZCN5
LCQCSNGTVKCDELA	OTOGL	821	Q3ZCN5
DRDSVCTCVEKNACK	PRR14L	1296	Q5THK1
NPLLIGSTCKKCDCS	LAMA4	176	Q16363
SVICKKCGLDTSQCE	EPHA6	366	Q9UF33
TQSCDKRDGSCSCKA	MEGF6	661	O75095
CECKKEAKGLQCDTC	USH2A	766	O75445
ACVVCEDCKKNVCTK	RPH3A	111	Q9Y2J0
EDCKKNVCTKCGVET	RPH3A	116	Q9Y2J0
EKCCLTGCTKEELSI	INSL6	176	Q9Y581
KVEAQSCQLCGTKVS	PRDM15	1221	P57071
AKGCELCSEVNGCLK	RSPO1	41	Q2MKA7
KTLTELNKCCGLCVC	SNAP23	71	O00161
TLKDVASCIDRCCKA	SNX7	241	Q9UNH6
AIQCDLISKCTCRSD	C12orf40	611	Q86WS4
QCDKCREILSVDCST	CLU	301	P10909
KCLECEKSFGCNSTL	ZNF572	301	Q7Z3I7
VGCECTLCSAKNKKD	TRPC1	191	P48995
VTVKSCDCLNGGSCV	VWDE	1176	Q8N2E2
CKECSKSFCVLSQLT	ZNF107	106	Q9UII5
TCKECGKGCITLSQL	ZNF624	781	Q9P2J8
FKCKECGKSCCILSQ	ZNF273	206	Q14593
CGKSCCILSQLTQHK	ZNF273	211	Q14593
SEGCIDITKCACLQL	SETDB2	296	Q96T68
KESALSKCQSCGLSC	SPATA2	376	Q9UM82
ISTICVTCKECEDLG	WDR90	1571	Q96KV7
TVIKCTRNVCKECGN	ZNF542P	91	Q5EBM4
DRCKITSVTCGCGNK	ZSWIM5	226	Q9P217
KCCNTTKCNEGPILE	PLAUR	191	Q03405
KCEECNNIFKSCSSL	ZNF695	241	Q8IW36
LRTHTGEKACECKEC	ZNF846	441	Q147U1
CKECGKVFSQCSRLT	ZNF616	551	Q08AN1
TGEKSCQCNECGKIF	ZNF33B	716	Q06732
ECTECGKVCSRVSSL	ZNF260	56	Q3ZCT1
TVKIGCNTCVCQDRK	VWF	841	P04275
VKRCTGCCNTSSVKC	PDGFA	126	P04085
LCGTCLIVSSVKDCQ	PHLPP2	176	Q6ZVD8
GDVCKEKICSCNEIE	SLITRK1	21	Q96PX8
CICSSVDPKNLCSKV	SPEM3	76	A0A1B0GUW6
CTKCEHGIIKECTLT	FAS	146	P25445
ECTLTSNTKCKEEGS	FAS	156	P25445
CKKDFCSVCSVLQEN	RNF34	81	Q969K3
CEECGKAFNCSSTLK	ZNF679	326	Q8IYX0
DCKVVSCKNCSIQRG	EZH1	596	Q92800
KDACTICECKDGQVT	PXDN	1431	Q92626
CSDCGKSFSCKSELI	ZNF551	421	Q7Z340
LCICQADGSVSCKRT	VWCE	591	Q96DN2
VARCSQKGTKVSCSC	STAB2	2096	Q8WWQ8
SVDQKNCALKCRESC	ROS1	66	P08922
CTCLDTVVRCSNKGL	SLIT2	731	O94813
GCTVCLKCINSLQKE	RFPL3	56	O75679
CDILNVTENSICCKT	PKHD1L1	311	Q86WI1
GCTVVCTLTKEDNRC	TET3	1086	O43151
CVKAFDPKTTCLQEC	TPH2	396	Q8IWU9
CNECGKSFCVKSGLI	ZNF33A	666	Q06730
CECKECGKTFSQALL	ZSCAN26	366	Q16670
TGEITCKCEECGKAF	ZNF90	196	Q03938
ECDKCGKAFSQCSLL	ZNF569	551	Q5MCW4
ECEECGKCFSQKGTL	ZNF418	371	Q8TF45
CSECGKAFRCKSQLI	ZNF26	176	P17031
TCKVCGKSCDSPLNL	ZNF687	1201	Q8N1G0
CNKTSKAIDGCELLC	WNT4	296	P56705
LSCVVCEKECTGVNS	ZBED9	601	Q6R2W3
TDLFTCGKCRKKNCT	TCEA2	256	Q15560
TCQACSVLGCAKVEA	KDR	736	P35968
KNSLCDSCEKCLTSV	ZNF12	136	P17014
IKKSCCADFECLENS	ZMYM1	456	Q5SVZ6
KLVKTCQEAATGECQ	TMEM129	296	A0AVI4
KSICGQKTTVLYECC	POSTN	66	Q15063
KCRCEANVVECSSLK	SLIT1	516	O75093
CTCEDCIKSKPKVDS	TNFRSF17	126	Q02223
ENECVSCSNCKKSLE	TNFRSF1A	176	P19438
SCSNCKKSLECTKLC	TNFRSF1A	181	P19438
NVETKEKSCVCVTCG	ZNF300	261	Q96RE9
EKSCVCVTCGKAFAK	ZNF300	266	Q96RE9
CAVCKVTIDGTGVSC	TNS2	46	Q63HR2
QDFTKKLGLCCITCT	ZMYM3	666	Q14202
KCNECGKTFCEKSAL	ZNF248	521	Q8NDW4
CKECTEIVNTPCLFK	ZNF461	221	Q8TAF7
TLCKEQQFCDCTISI	ZBTB40	16	Q9NUA8
QCKEDSTCISLPKVC	TMPRSS6	496	Q8IU80
NCVKKTCAESDFVCN	VLDLR	66	P98155
ECKECGKAFTRSCQL	ZNF266	241	Q14584